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CHEMILUMNESCENCE WITH A SINGLE 
FARADAC ELECTRODE 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application claims the benefit of priority as a divi 
sional of U.S. patent application Ser. No. 13/485,662, filed on 
May 31, 2012, which claims the benefit of priority as a divi 
sional of U.S. patent application Ser. No. 1 1/446,596, filed on 
Jun. 2, 2006, which claims the benefit of priority to U.S. 
Provisional Patent Application No. 60/686,935, filed on Jun. 
3, 2005; and U.S. Provisional Patent Application No. 60/695, 
163, filedon Jun. 30, 2005; and U.S. Provisional Patent Appli 
cation No. 60/737,472, filed on Nov. 17, 2005, the complete 
disclosures of which are all incorporated herein by reference. 
FIELD 
This invention relates to an electrochemical apparatus 
comprising an electrochemical cell with a faradaic working 
electrode and a capacitive counter electrode and methods of 
the cells use. The electrochemical cell is useful for control 
ling the redox products generated and/or the timing of the 
redox product generation. In some embodiments, it is useful 
for generating electrochemiluminescence and methods of 
using the same. 
BACKGROUND 
Electrochemiluminescent (ECL) methods and systems are 
useful in a variety of applications including medical diagnos 
tics, food and beverage testing, environmental monitoring, 
manufacturing quality control, drug discovery and basic sci 
entific research. There are a number of commercially avail 
able instruments that utilize ECL for analytical measure 
mentS. 
Species that can be induced to emit ECL (ECL moieties) 
have been used as ECL labels in various testing procedures. 
The light generated by ECL labels can be used as a reporter 
signal in diagnostic procedures (Bard et al., U.S. Pat. No. 
5,238,808). For instance, an ECL label can be covalently 
coupled to a binding agent Such as an antibody or a nucleic 
acid probe, and the participation of the binding reagent in a 
binding interaction can be monitored by measuring ECL 
emitted from the ECL label. Alternatively, the ECL signal 
from an ECL-active compound can be indicative of the 
chemical environment (see, e.g., U.S. Pat. No. 5,641,623 
which describes ECL assays that monitor the formation or 
destruction of ECL coreactants). 
For more background on ECL, ECL labels, ECL assays and 
instrumentation for conducting ECL assays see U.S. Pat. Nos. 
5,093,268; 5,147,806; 5,324.457; 5,591581: 5,597,910; 
5,641,623: 5,643,713; 5,679,519; 5,705,402; 5,846,485; 
5,866,434; 5,786,141; 5,731, 147; 6,066,448; 6,136,268: 
5,776,672; 5,308,754:5,240,863; 6,207,369; and 5,589,136 
and Published PCT Nos. WO99/63347; WO00/03233; 
WO99/58962; WO99/32662; WO99/14599; WO98/12539; 
WO97736931 and WO98757154. 
Commercially available ECL instruments are widely used 
for reasons including their excellent sensitivity, dynamic 
range, precision, and tolerance of complex sample matrices. 
Many commercially available instruments use flow cell 
based designs with permanent reusable flow cells. The use of 













Some limitations, for example, in assay throughput. In some 
applications, for example, the screening of chemical libraries 
for potential therapeutic drugs, assay instrumentation should 
perform large numbers of analyses at high speeds on Small 
quantities of samples. 
A variety oftechniques have been developed for increasing 
assay throughput and decreasing sample size. The use of 
multi-well assay plates allows for the parallel processing and 
analysis of multiple samples distributed in multiple wells of a 
plate. Typically, samples and reagents are stored, processed 
and/or analyzed in multi-well assay plates (also known as 
microplates or microtiter plates). Multi-well assay plates can 
take a variety of forms, sizes and shapes. For convenience, 
Some standards have appeared for some instrumentation used 
to process samples for high throughput assays. Multi-well 
assay plates typically are made in standard sizes and shapes 
and with standard arrangements of wells. Some well estab 
lished arrangements of wells include those found on 96-well 
plates (12x8 array of wells), 384-well plates (24x16 array of 
wells) and 1536-well plate (48x32 array of wells). The Soci 
ety for Biomolecular Screening and ANSI have published 
microplate specifications for a variety of plate formats (see, 
http://www.sbsonline.org). 
There is a need for ECL assay systems, and assays systems 
based on other electrochemical methods, that require lower 
sample Volume, and are less expensive, faster, and more sen 
sitive. As these assays move to the nanoscale to address these 
needs, it is increasingly difficult to separate the working elec 
trode from the counter electrode: As the working and counter 
electrodes are brought closer together in the same cell, unde 
sirable redox byproducts formed at the counter electrode can 
interact with species at the working electrode. 
To date, cells using one capacitive and one faradaic elec 
trode have been used in Solid state systems, for example, to 
inject charge into thin layers of luminescent organic polymers 
to aid the observation of spectroscopic properties. In Such 
systems, one electrode contacts the polymer layer and the 
other electrode is a small tip separated from the polymer layer 
by a ~10 nm insulating layer of impurities or air. See for 
example, Adams, et al., J. Phys. Chem. B, 2000, 104, 6728. 
These cells are not electrochemical cells, do not use an elec 
trolyte solution, and are not designed to contain an electrolyte 
Solution. Configurations involving a capacitive electrode and 
a reference electrode have been used to examine double layer 
effects. See, for example, Grahame, Chem. Rev., 1947, 41, 
441. These studies focus on the importance of the polarized 
electrode. Any faradaic effects at the reference electrode were 
not of interest and were neglected. 
There remains a need for an electrochemical apparatus that 
reduces the introduction of undesirable electrochemically 
generated byproducts into the sample. 
There remains a need for an electrochemical apparatus that 
separately controls the timing of the generation of oxidation 
and reduction products. 
SUMMARY 
The present invention provides an apparatus comprising an 
electrochemical cell comprising: a faradaic working elec 
trode and a capacitive counter electrode wherein the electro 
chemical cell is capable of receiving an electrolyte Solution 
that can simultaneously contact said faradaic working elec 
trode and said capacitive counter electrode. 
US 8,840,774 B2 
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Also provided are methods of determining the presence or 
amount of an analyte in a sample comprising the steps of: 
(a) optionally preprocessing the sample: 
(b) contacting a faradaic working electrode to a solution 
comprising the optionally pre-processed sample; and an elec 
trolyte; 
(c) contacting a capacitive counter electrode to the Solu 
tion; 
(d) Supplying electrical energy between the faradaic work 
ing electrode and the capacitive counter electrode sufficient to 
provide for faradaic charge transfer at the faradaic working 
electrode: 
(e) measuring at least one of (i) light, (ii) current, (iii) 
Voltage, and (iv) charge to determine the presence or amount 
of the analyte in the sample. 
Also provided are methods of generating at least one elec 
trochemical product at a working electrode while generating 
a discordantly Smaller amount of electrochemical byproduct 
at a counter electrode, comprising the steps of 
contacting a faradaic working electrode with an electrolyte 
Solution; 
contacting a capacitive counter electrode with the electro 
lyte Solution; and 
applying electrical energy between the faradaic working 
electrode and the capacitive counter electrode wherein the 
faradaic charge transferred across the faradaic working elec 
trode is at least-about 10 times the faradaic charge transferred 
across the capacitive counter electrode, thus generating a 
discordantly smaller amount of electrochemical byproduct at 
the counter electrode. 
In this method and any methods disclosed or claimed 
herein, the faradaic and the capacitive electrodes may be 
placed in contacted with the electrolyte or sample solution in 
any order. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1. Schematic diagram showing the system Pt/water/ 
SiO/Si with the possibility of lateral tip movement to gener 
ate fresh contact surface. The tip was attached to a translation 
stage that could be moved with an inchworm motor, a 
micrometer, or by hand. 
FIG. 2. Charging current as a function of time in a system 
of Pt/water/SiO/Si under a bias of 1 V applied between Pt 
and Si. After the charging current reached baseline, the circuit 
was disconnected for about 8 S and reconnected again still 
under the same bias; only a very Small charging current was 
seen as shown in the inset. 
FIG. 3. Charging current recorded during the relative 
movement under a bias of -1 V applied between Pt and Si in 
a system of Pt/water/SiO/Si. Lateral scan rate, ~1 cm/s. 
Inset: Charging current as a function of bias with stationary 
tip at a scan rate of 100 mV/s. 
FIG. 4. Charging current, as in FIG. 3 during repeated 
steps, i.e., a stop-and-go lateral movement, under a constant 
bias of -1 V between Pt and Si. The current increased as the 
water drop movement started and decreased when the move 
ment stopped, with a brief steady state charging current dur 
ing the movement. 
FIG. 5. Charging current (bottom) and electrogenerated 
chemiluminescence (top) produced in the system of Pt/water/ 
SiO/Si with continuous applied potential pulses from 1.4 V 
to -0.5V between Pt and Si, in aqueous 0.5 mM Ru(bpy).", 
0.10M tripropylamine (TPA) and 0.10M Tris/0.10 MLiCIO 
buffer (pH=8). Inset: Micrograph of an ECL image from a 25 
um Pt tip obtained with an optical microscope in a separate 














FIG. 6. Schematic diagram showing a motor driven, mov 
ing, blocked counter electrode, e.g. a conductive wire or tape 
coated with an insulating layer, through a solution containing 
an electrolyte under a bias to produce a continuous faradaic 
reaction at the working electrode. 
DETAILED DESCRIPTION 
The following description refers to the accompanying 
drawings in which, in the absence of a contrary representa 
tion, the same numbers in different drawings represent simi 
lar elements. The implementations in the following descrip 
tion do not represent all implementations consistent with 
principles of the claimed invention. Instead, they are merely 
Some examples of systems and methods consistent with those 
principles. It is to be understood that both the foregoing 
general description and the following detailed description are 
exemplary and explanatory only and are not restrictive of the 
invention as claimed. 
I. DEFINITIONS 
As used in the present specification, the following words 
and phrases are generally intended to have the meanings as set 
forth below, except to the extent that the context in which they 
are used indicates otherwise. These definitions are placed in 
this section for the reader's convenience. Definitions for other 
terms, words and phrases, which may be found in other sec 
tions of this application, also describe the intended meanings, 
except to the extent that the context in which they are used 
indicates otherwise. 
A. General Definitions 
The term “aliphatic, as used herein, is defined as in The 
American Heritage R. Dictionary of the English Language, 
Fourth Edition Copyright (C) 2000 and encompasses organic 
chemical compounds in which the carbonatoms are linked in 
open chains. The open chains comprise from 1 to 20 carbon 
atoms, or from 1 to 13, or from 1 to 6 carbonatoms. When an 
aliphatic group is unsaturated there can be from 1 to 10, or 
from 1 to 6, or from 1 to 3 points of unsaturation. The number 
of carbon atoms in an aliphatic group can be indicated by a 
subscript on a “C” (for example, “Caliphatic' represents an 
aliphatic group comprising 3 carbon atoms). Likewise, 
ranges can be expressed in the Subscript. For example “Co 
aliphatic' encompasses aliphatic groups of from 1 to 10 car 
bon atoms inclusive. Examples of aliphatic groups include, 
but are not limited to, methyl, ethyl, propyl, isopropyl. n-bu 
tyl, sec-butyl, tert-butyl, pentyl, 2-pentyl, isopentyl, neopen 
tyl, hexyl, 2-hexyl, 3-hexyl, 3-methylpentyl, ethene, propene, 
ethyne, butene, propyne, butyne, and the like. When an ali 
phatic group having a specific number of carbons is named 
using the Subscripted C notation, all isomers having that 
number of carbons are intended to be encompassed. Aliphatic 
groups can be optionally Substituted by at least one hydro 
philic functional group, as defined herein. In addition, ali 
phatic groups useful as ECL moieties and as ECL coreactants 
may also comprise additional functional groups and may have 
a single (i.e., monodentate ligand) or multiple (i.e., bidentate 
or polydentate ligands) points of attachment. Such aliphatic 
groups are well known in the art and are described in Elec 
trogenerated Chemiluminescence, Bard, Editor, Marcel. 
Dekker, (2004); Knight, A and Greenway, G. Analyst 119: 
879-890 1994. 
The term “hydrophilic functional group' refers to a func 
tional group that facilitates or that increases the solubility of 
US 8,840,774 B2 
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a molecule in water. Examples include, but are not limited to, 
groups such as hydroxyl ( OH), aldehyde ( C(O)H), 
hydroxycarbonyl ( C(OH)(C=O)H), amino ( NH), ami 
nocarbonyl ( CONH), amidine ( C(=NH)NH), imino 
(—C—NH), cyano (—CN), nitro ( NO), nitrate ( NO), 
sulfate ( -SO), sulfonate ( SOH), phosphate ( PO), 
phosphonate ( PHO), silicate ( SiHO), carboxylate 
(—COOH), borate ( BHO), guanidinium ( HN C 
(—NH) NH), carbamide ( HNC(O)NH), carbamate 
(—HNC(O)NH), carbonate (—CO), sulfamide (—S(O) 
NH), silyl ( SiH and/or —Si(OH)), siloxy ( OSiRI 
and/or —OSi(OH)), amide and the like. 
The term “binding partner as used herein, means a Sub 
stance that can bind specifically to an analyte of interest. In 
general, specific binding is characterized by a relatively high 
affinity and a relatively low to moderate capacity. Nonspecific 
binding usually has a low affinity with a moderate to high 
capacity. Typically, binding is considered specific when the 
affinity constant Ka is higher than about 10 M'. For 
example, binding may be considered specific when the affin 
ity constant Ka is higher than about 10M'. A higher affinity 
constant indicates greater affinity, and thus typically greater 
specificity. For example, antibodies typically bind antigens 
with an affinity constant in the range of 10M to 10M or 
higher. 
Examples of binding partners include complementary 
nucleic acid sequences (e.g., two DNA sequences which 
hybridize to each other; two RNA sequences which hybridize 
to each other; a DNA and an RNA sequence which hybridize 
to each other), an antibody and an antigen, a receptor and a 
ligand (e.g., TNF and TNFr-I, CD142 and Factor VIIa, B7-2 
and CD28, HIV-1 and CD4, ATR/TEM8 or CMG and the 
protective antigen moiety of anthrax toxin), an enzyme and a 
Substrate, or a molecule and a binding protein (e.g., vitamin 
B12 and intrinsic factor, folate and folate binding protein). 
As mentioned above, antibodies are an example of a bind 
ing partner. The term “antibody, as used herein, means an 
immunoglobulin or a part thereof, and encompasses any 
polypeptide (with or without further modification by sugar 
moieties (mono and polysaccharides)) comprising an antigen 
binding site regardless of the Source, method of production, or 
other characteristics. The term includes, for example, poly 
clonal, monoclonal, monospecific, polyspecific, humanized, 
single chain, chimeric, synthetic, recombinant, hybrid, 
mutated, and CDR grafted antibodies as well as fusion pro 
teins. A part of an antibody can include any fragment which 
can bind antigen, including but not limited to Fab, Fab', 
F(ab'), Facb, Fv, Schv, Fd, V, and V. 
A large number of monoclonal antibodies that bind to 
various analytes of interest are available, as exemplified by 
the listings in various catalogs, such as: Biochemicals and 
Reagents for Life Science Research, Sigma-Aldrich Co., P.O. 
Box 14508, St. Louis, Mo., 63178 (1999); the Life Technolo 
gies Catalog, Life Technologies, Gaithersburg, Md., and the 
Pierce Catalog, Pierce Chemical Company, P.O. Box 117. 
Rockford, Ill. 61105 (1994). 
Other exemplary monoclonal antibodies include those that 
bind specifically to 3-actin, DNA, digoxin, insulin, progest 
erone, human leukocyte markers, human interleukin-10, 
human interferon, human fibrinogen, p53, hepatitis B virus or 
a portion thereof, HIV virus or a portion thereof, tumor necro 
sis factor, or FK-506. In certain embodiments, the mono 
clonal antibody is chosen from antibodies that bind specifi 
cally to at least one of T4, T3, free T3, free T4, TSH (thyroid 
stimulating hormone), thyroglobulin, TSH receptor, 
prolactin, LH (luteinizing hormone), FSH (follicle stimulat 













man Chorionic Gondaotropin), hCG+f3, SHBG (sex hor 
mone-binding globulin), DHEA-S (dehydroepiandrosterone 
sulfate), hCH (human growth hormone), ACTH (adrenocor 
ticotropic hormone), cortisol, insulin, ferritin, folate, RBC 
(red blood cell) folate, vitamin B12, vitamin D, C-peptide, 
troponin T. CKMB (creatine kinase-myoglobin), myoglobin, 
pro-BNP (brain natriuretic peptide), HbsAg (hepatitis B sur 
face antigen), HbeAg (hepatitis Be antigen), HIV antigen, 
HIV combined, H. pylori, B-CrossLaps, osteocalcin, PTH 
(parathyroid hormone), IgE, digoxin, digitoxin, AFP (C-fe 
toprotein), CEA (carcinoembryonic antigen), PSA (prostate 
specific antigen), free PSA, CA (cancer antigen) 19-9, CA 
12-5, CA 72-4, cyfra 21-1, NSE (neuron specific enolase), 
S-100, P1NP (procollagen type 1 N-propeptide), PAPP-A 
(pregnancy-associated plasma protein-A), Lp-PLA2 (lipo 
protein-associated phospholipase A2), SCD40L (soluble 
CD40 Ligand), IL 18, and Survivin. 
Other exemplary monoclonal antibodies include anti-TPO 
(antithyroid peroxidase antibody), anti-HBc (Hepatitis Bc 
antigen), anti-HBc/IgM, anti-HAV (hepatitis A virus), anti 
HAV/IgM, anti-HCV (hepatitis C virus), anti-HIV, anti-HIV 
p-24, anti-rubella IgG, anti-rubella IgM, anti-toxoplasmosis 
IgG, anti-toxoplasmosis IgM, anti-CMV (cytomegalovirus) 
IgG, anti-CMV IgM, anti-HGV (hepatitis G. virus), and anti 
HTLV (human T-lymphotropic virus). 
Further examples of binding partners include binding pro 
teins, for example, vitamin B12 binding protein, DNA bind 
ing proteins such as the Superclasses of basic domains, zinc 
coordinating DNA binding domains, Helix-turn-helix, beta 
scaffold factors with minor groove contacts, and other tran 
Scription factors that are not antibodies. 
The term “labeled binding partner,” as used herein, means 
a binding partner that is labeled with an atom, moiety, func 
tional group, or molecule capable of generating, modifying or 
modulating a detectable signal. For example, in a radiochemi 
cal assay, the labeled binding partner may be labeled with a 
radioactive isotope of iodine. Alternatively, the labeled bind 
ing partner antibody may be labeled with an enzyme-e.g., 
horseradish peroxidase that can be used in a colorimetric 
assay. The labeled binding partner may also be labeled with a 
fluorophore, such as one useful in fluorescence measure 
ments, time-resolved fluorescence measurements or a fluo 
rescence resonance energy transfer (FRET) measurements. 
Exemplary reporters are disclosed in Hemmila, et al., J. Bio 
chem. Biophys. Methods, vol. 26, pp. 283-290 (1993); Kaka 
bakos, et al., Clin. Chem. Vol. 38, pp. 338-342 (1992); Xu, et 
al., Clin. Chem., pp. 2038-2043 (1992); Hemmila, et al., 
Scand. J. Clin. Lab. Invest., vol. 48, pp. 389-400 (1988); 
Bioluminescence and Chemiluminescence Proceedings of 
the 9th International Symposium 1996, J. W. Hastings, et al., 
Eds. Wiley, New York, 1996: Bioluminescence and Chemi 
luminescence Instruments and Applications, Knox Van Dyre, 
Ed., CRC Press, Boca Raton, 1985: I. Hemmila, Applications 
of Fluorescence in Immunoassays, Chemical Analysis, Vol 
ume 117, Wiley, New York, 1991; and Blackburn, et al., Clin. 
Chem., vol. 37, p. 1534 (1991). 
Further examples of labeled binding partners include bind 
ing partners that are labeled with an electrochemiluminescent 
moiety (ECL moiety), functional group, or molecule that is 
useful for generating a signal in an electrochemiluminescent 
(ECL) assay. The ECL moiety may be any compound that can 
be induced to repeatedly emit electromagnetic radiation by 
direct exposure to an electrical energy source. Such moieties, 
functional groups, or molecules are disclosed in U.S. Pat. 
Nos. 5,962,218; 5,945,344; 5,935,779; 5,858,676; 5,846,485; 
5,811,236; 5,804,400; 5,798.083; 5,779,976; 5,770,459: 
5,746,974; 5,744,367; 5,731,147; 5,720,922; 5,716,781; 
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5,714,089; 5,705,402; 5,700,427; 5,686,244; 5,679,519; 
5,643,713; 5,641,623: 5,632,956; 5,624,637; 5,610,075; 
5,597,910; 5,591,581: 5,543,112, 5,466,416; 5.453,356; 
5,310,687: 5,296,191; 5,247,243; 5,238,808: 5,221,605; 
5,189,549; 5,147,806; 5,093,268; 5,068,088; 5,061445; and 
6,808,939; Dong, L. et al., Anal. Biochem. Vol. 236, pp. 
344-347 (1996); Blohm, et al., Biomedical Products, vol. 21, 
No. 4:60 (1996); Jameison, et al., Anal. Chem. Vol. 68, pp. 
1298–1302 (1996); Kibbey, et al., Nature Biotechnology, vol. 
14, no. 3, pp. 259-260 (1996); Yu, et al., Applied and Envi 
ronmental Microbiology, Vol. 62, no. 2, pp. 587-592 (1996); 
Williams, American Biotechnology, p. 26—(January, 1996); 
Darsley, et al., Biomedical Products, vol. 21, no. 1, p. 133 
(January, 1996); Kobrynski, et al., Clinical and Diagnostic 
Laboratory Immunology, Vol. 3, no. 1, pp. 42-46 (January 
1996); Williams, IVD Technology, pp. 28-31 (November, 
1995): Deaver, Nature, vol. 377, pp. 758-760 (Oct. 26, 1995); 
Yu, et al., BioMedical Products, vol. 20, no. 10, p. 20 (Octo 
ber, 1995); Kibbey, et al., BioMedical Products, vol. 20, no.9, 
p. 116 (September, 1995); Schutzbank, et al., Journal of Clini 
cal Microbiology, Vol. 33, pp. 2036-2041 (August, 1995); 
Stern, et al., Clinical Biochemistry, vol. 28, pp. 470-472 (Au 
gust, 1995); Carlowicz, Clinical Laboratory News, Vol. 21, 
no. 8, pp. 1-2 (August 1995); Gatto-Menking, et al., Biosen 
sors & Bioelectronics, vol. 10, pp. 501-507 (July, 1995);Yu, 
et al., Journal of Bioluminescence and Chemiluminescence, 
vol. 10, pp. 239-245 (1995); Van Gemen, et al., Journal of 
Virology Methods, vol. 49, pp. 157-168 (1994): Yang, et al., 
Bio/Technology, Vol. 12, pp. 193-194 (1994); Kenten, et al., 
Clinical Chemistry, vol. 38, pp. 873-879 (1992); Kenten, 
Non-radioactive Labeling and Detection of Biomolecules, 
Kessler, Ed., Springer, Berlin, pp. 175-179 (1992); Gudi 
bande, et al., Journal of Molecular and Cellular Probes, Vol. 6, 
pp. 495-503 (1992); Kenten, et al., Clinical Chemistry, Vol. 
37, pp. 1626-1632 (1991); Blackburn, et al., Clinical Chem 
istry, vol. 37, pp. 1534-1539 (1991), Electrogenerated 
Chemiluminescence, Bard, Editor, Marcel Dekker, (2004), 
and U.S. Pat. No. 5,935,779. In certain embodiments, the 
electrochemiluminescent group can comprise a metal. Such 
as ruthenium or osmium. In certain embodiments, the binding 
partner can be labeled with a ruthenium moiety, such as a 
tris-bipyridyl-ruthenium group Such as ruthenium (II) tris 
bipyridine (IRu(bpy)"). 
The term “analyte as used herein, means any molecule, or 
aggregate of molecules, including a cell or a cellular compo 
nent of a virus, found in a sample. Examples of analytes to 
which the binding partner can specifically bind include bac 
terial toxins, viruses, bacteria, proteins, hormones, DNA, 
RNA, drugs, antibiotics, nerve toxins, and metabolites 
thereof. Also included in the scope of the term “analyte' are 
fragments of any molecule found in a sample. An analyte may 
be an organic compound, an organometallic compound oran 
inorganic compound. An analyte may be a nucleic acid (e.g., 
DNA, RNA, a plasmid, a vector, or an oligonucleotide), a 
protein (e.g., an antibody, an antigen, a receptor, a receptor 
ligand, or a peptide), a lipoprotein, a glycoprotein, a ribo- or 
deoxyribonucleoprotein, a peptide, a polysaccharide, a 
lipopolysaccharide, a lipid, a fatty acid, a vitamin, an amino 
acid, a pharmaceutical compound (e.g., tranquilizers, barbi 
turates, opiates, alcohols, tricyclic antidepressants, benzodi 
azepines, anti-virals, anti-fungals, antibiotics, steroids, car 
diac glycosides, or a metabolite of any of the preceding), a 
hormone, a growth factor, an enzyme, a coenzyme, anapoen 
Zyme, a hapten, a lectin, a Substrate, a cellular metabolite, a 
cellular component or organelle (e.g., a membrane, a cell 
wall, a ribosome, a chromosome, a mitochondria, or a cytosk 













pesticide, herbicides, and environmental pollutants. The defi 
nition further includes complexes comprising one or more of 
any of the examples set forth within this definition. 
Further examples of analytes include bacterial pathogens 
Such as Aeromonas hydrophile and other species (spp.); 
Bacillus anthracis, Bacillus cereus, Botulinum neurotoxin 
producing species of Clostridium, Brucella abortus, Bru 
cella melitensis, Brucella suis, Burkholderia mallei (for 
mally Pseudomonas mallei); Burkholderia pseudomallei 
(formerly Pseudomonas pseudomallei); Campylobacter 
jejuni; Chlamydia psittaci, Clostridium botulinum, 
Clostridium perfiringens, Cowdria ruminantium (Heartwa 
ter); Coxiella burnetii: Enterovirulent Escherichia coli group 
(EEC Group) such as Escherichia coli enterotoxigenic 
(ETEC), Escherichia coli enteropathogenic (EPEC), 
Escherichia coli O157:H7 enterohemorrhagic (EHEC), 
and Escherichia coli enteroinvasive (EIEC); Ehrlichia spp. 
such as Ehrlichia chafeensis, Francisella tularensis, 
Legionella pneumophilia, Liberobacter africanus, Libero 
bacter asiaticus, Listeria monocytogenes; miscellaneous 
enterics such as Klebsiella, Enterobacter, Proteus, Citro 
bacter, Aerobacter, Providencia, and Serratia, Mycobacte 
rium bovis, Mycobacterium tuberculosis, Mycoplasma 
capricolum, Mycoplasma mycoides ssp mycoides, Perono 
sclerospora philippinensis, Phakopsora pachyrhizii Plesi 
Omonas Shigelloides, Ralstonia Solanacearum race 3, biovar 
2: Rickettsia prowazekii, Rickettsia rickettsii; Salmonella 
spp.; Schlerophthora rayssiae var zeae, Shigella spp., Sta 
phylococcus aureus, Streptococcus, Synchytrium endobioti 
cum, Vibrio cholerae non-O1; Vibrio cholerae O1; Vibrio 
parahaemolyticus and other Vibrios; Vibrio vulnificus, Xan 
thomonas Oryzae, Xylella fastidiosa (citrus variegated chlo 
rosis strain); Yersinia enterocolitica and Yersinia pseudotu 
berculosis; and Yersinia pestis. 
Further examples of analytes include viruses such as Afri 
can horse sickness virus; African Swine fever virus; Akabane 
virus; Avian influenza virus (highly pathogenic); Bhanja 
virus; Blue tongue virus (Exotic); Camel pox virus; Cercop 
ithecine herpesvirus 1; Chikungunya virus; Classical Swine 
fever virus; Coronavirus (SARS): Crimean-Congo hemor 
rhagic fever virus; Dengue viruses; Dugbe virus; Ebola 
viruses: Encephalitic viruses such as Eastern equine encepha 
litis virus, Japanese encephalitis virus, Murray Valley 
encephalitis, and Venezuelan equine encephalitis virus; 
Equine morbillivirus; Flexal virus; Foot and mouth disease 
virus; Germiston virus: Goat pox virus; Hantaan or other 
Hantaviruses; Hendra virus; Issyk-kul virus; Koutango virus; 
Lassa fever virus; Louping-ill virus; Lumpy skin disease 
virus; Lymphocytic choriomeningitis virus; Malignant 
catarrhal fever virus (Exotic); Marburg virus; Mayaro virus: 
Menangle virus; Monkeypox virus; Mucambo virus; New 
castle disease virus (VVND): Nipah Virus; Norwalk virus 
group: Oropouche virus: Orungo virus; Peste Des Petits 
Ruminants virus; Piry virus; Plum Pox Potyvirus; Poliovirus: 
Potato virus; Powassan virus; Rift Valley fever virus; Rinder 
pest virus; Rotavirus; Semliki Forest virus; Sheep pox virus: 
South American hemorrhagic fever viruses such as Flexal, 
Guanarito, Junin, Machupo, and Sabia; Spondweni virus; 
Swine vesicular disease virus; Tick-borne encephalitis com 
plex (flavi) viruses such as Central European tick-borne 
encephalitis, Far Eastern tick-borne encephalitis, Russian 
spring and Summerencephalitis, Kyasanur forest disease, and 
Omsk hemorrhagic fever, Variola major virus (Smallpox 
virus); Variola minor virus (Alastrim); Vesicular stomatitis 
virus (Exotic); Wesselbron virus; West Nile virus; Yellow 
fever virus; viruses from the family papovaviridae, including 
polyomaviruses such as SV40, JC and BK and including 
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papillomaviruses (e.g., HPV); parvoviruses (e.g., B19 and 
RA-1); and viruses from the family Picornaviridae, including 
rhinoviruses and Coxsackie B. Other viruses that can com 
prise a target nucleic acid sequence include species not men 
tioned above belonging to the families Adenoviridae, 
Arenaviridae, Arterivirus, Astroviridae, Baculoviridae, Bad 
navirus, Bamaviridae, Birnaviridae, Bromoviridae, Bun 
yaviridae, Caliciviridae, Capillovirus, Carla virus, Cauli 
movirus, Circoviridae, Closterovirus, Comoviridae, 
Coronaviridae, Corticoviridae, Cystoviridae, Deltavirus, 
Dianthovirus, Enamovirus, Filoviridae, Flaviviridae, Furovi 
rus, Fuselloviridae, Geminiviridae, Hepadnaviridae, Herpes 
viridae, Hordeivirus, Hypoviridae, Idaeovirus, Inoviridae, 
Iridoviridae, Leviviridae, Lipothrixviridae, Luteovirus, 
Machlomovirus, Marafivirus, Microviridae, Myoviridae, 
Necrovirus, Nodaviridae, Orthomyxoviridae, Paramyxoviri 
dae, Partitiviridae, Parvoviridae, Phycodnaviridae, Plasma 
viridae, Podoviridae, Polydnaviridae, Potexvirus, Potyviri 
dae, Poxviridae, Reoviridae, Retroviridae, Rhabdoviridae, 
Rhizidiovirus, Sequiviridae, Siphoviridae, Sobemovirus, 
Tectiviridae, Tenuivirus, Tetraviridae, Tobamovirus, Tobravi 
rus, Togaviridae, Tombusviridae, Totiviridae, Tymovirus, and 
Umbra virus. 
Further examples of analytes include toxins such as Abrin; 
Aflatoxins. Botulinum neurotoxin; Ciguatera toxins: 
Clostridium perfingens epsilon toxin; Conotoxins; Diac 
etoxyscirpenol; Diphtheria toxin; Grayanotoxin; mushroom 
toxins such as amanitins, gyromitrin, and orellanine; Phyto 
haemagglutinin; Pyrrolizidine alkaloids; Ricin; shellfish tox 
ins (paralytic, diarrheic, neurotoxic or amnesic) Such as sax 
itoxin, akadaic acid, dinophysis toxins, pectenotoxins, 
yessotoxins, brevetoxins, and domoic acid; Shigatoxins: 
Shiga-like ribosome inactivating proteins; Snake toxins; Sta 
phylococcal enterotoxins; T-2 toxin; and Tetrodotoxin. 
Further examples of analytes include prion proteins such as 
the Bovine spongiform encephalopathy agent. 
Further examples of analytes include parasitic protozoa 
and worms, such as: Acanthamoeba and other free-living 
amoebae; Anisakis sp. and other related worms Ascaris lum 
bricoides and Trichuris trichiura, Cryptosporidium parvum, 
Cyclospora cavetanensis, Diphyllobothrium spp.; Entam 
oeba histolytica, Eustrongylides spp., Giardia lamblia, 
Nanophyetus spp.; Shistosoma spp., Toxoplasma gondii; and 
Trichinella. 
Further examples of analytes include fungi such as: 
Aspergillus spp., Blastomyces dermatitidis, Candida, Coc 
cidioides immitis, Coccidioides posadasii, Cryptococcus 
neoformans. Histoplasma capsulatum: Maize rust; Rice 
blast; Rice brown spot disease; Rye blast; Sporothrix 
schenckii; and wheat fungus. 
Further examples of analytes include genetic elements, 
recombinant nucleic acids, and recombinant organisms. Such 
aS 
(1) nucleic acids (synthetic or naturally derived, contigu 
ous or fragmented, in host chromosomes or in expression 
vectors) that can encode infectious and/or replication compe 
tent forms of any of the select agents. 
(2) nucleic acids (synthetic or naturally derived) that 
encode the functional form(s) of any of the toxins listed if the 
nucleic acids 
(i) are in a vector or host chromosome; 
(ii) can be expressed in vivo or in vitro; or 
(iii) are in a vector or host chromosome and can be 
expressed in vivo or in vitro: 
(3) nucleic acid protein complexes that are locations of 













(i) viral nucleic acid protein complexes that are precur 
sors to viral replication; 
(ii) RNA-protein complexes that modify RNA structure 
and regulate protein transcription events; or 
(iii) Nucleic acid protein complexes that are regulated by 
hormones or secondary cell signaling molecules. 
(4) viruses, bacteria, fungi, and toxins that have been 
genetically modified. 
Further examples of analytes include immune response 
molecules to the above-mentioned analyte examples such as 
IgA, Ig), IgE, IgG, and IgM. 
The term “analog of the analyte, as used herein, refers to 
a substance that competes with the analyte of interest for 
binding to a binding partner. An analog of the analyte may be 
a known amount of the analyte of interest itself that is added 
to compete for binding to a specific binding partner with 
analyte of interest present in a sample. Examples of analogs 
of the analyte include azidothymidine (AZT), an analog of a 
nucleotide which binds to HIV reverse transcriptase, puro 
mycin, an analog of the terminal aminoacyl-adenosine part of 
aminoacyl-tRNA, and methotrexate, an analog of tetrahydro 
folate. Other analogs may be derivatives of the analyte of 
interest. The term “labeled analog of the analyte', as used 
herein, is defined in an analogous manner to labeled binding 
partner. 
As used herein, the term “support.” refers to any of the 
ways for immobilizing binding partners that are known in the 
art, such as membranes, beads, particles, electrodes, or even 
the walls or-surfaces of a container. The Support may com 
prise any material on which the binding partner is conven 
tionally immobilized, such as nitrocellulose, polystyrene, 
polypropylene, polyvinyl chloride, EVA, glass, carbon, 
glassy carbon, carbon black, carbon nanotubes or fibrils, 
platinum, palladium, gold, silver, silver chloride, iridium, 
rhodium, or alloys comprising the metallic elements in this 
list. In one embodiment, the Support is a bead, Such as a 
polystyrene bead or a magnetizable bead. As used herein, the 
term “magnetizable bead’ encompasses magnetic, paramag 
netic, and Superparamagnetic beads and/or particles. In Vari 
ous embodiments, beads can have a number of different sizes, 
for example, larger than about 3 mm, Smaller than about 3 
mm, Smaller than about 1 mm, Smaller than about 0.1 mm, 
smaller than about 100m, smaller than about 10 um, smaller 
than about 5um, about 2.8 Lim, about 1 um, Smaller than about 
1 Jum, Smaller than about 0.5um, about 0.1 um, or Smaller than 
about 0.1 um. Bead size can range from about 0.1 um to about 
5 mm, or from about 0.1 um to about 3 mm, or from about 1 
um to about 3 um, or from about 2.8 um to about 5 um. 
Combinations of beads sizes can also be used. In one embodi 
ment, the Support is a microcentrifuge tube or at least one well 
of a multiwell plate. 
The term “dry composition,” as used herein, means that the 
composition has a moisture content of less than or equal to 
about 5% by weight, relative to the total weight of the com 
position. Examples of dry compositions include composi 
tions that have a moisture content of less than or equal to 
about 3% by weight relative to the total weight of the com 
position, of less than or equal to about 1% by weight relative 
to the total weight of the composition and compositions that 
have a moisture content ranging from about 1% to about 3% 
by weight, relative to the total weight of the composition. 
In some embodiments of the present invention, the assay 
performance-substance is a dry composition. In some 
embodiments of the present invention, the ECL moiety is a 
dry composition. 
The term "sample, as used herein, comprises liquids that 
can contain the analyte. The term “liquid as used herein 
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comprises—in addition to the more traditional definition of 
liquid-colloids, Suspensions, slurries, and dispersions of 
particles in a liquid wherein the particles have a sedimenta 
tion rate due to earth's gravity of less than about 1 mm/s. The 
sample can be drawn from any source upon which analysis is 
desired. For example, the sample can arise from body or other 
biological fluid. Such as blood, plasma, serum, milk, semen, 
amniotic fluid, cerebral spinal fluid, sputum, bronchoalveolar 
lavage, tears, saliva, urine, or stool. Alternatively, the sample 
can be a water sample obtained from a body of water, Such as 
lake or river. The sample can also be prepared by dissolving or 
Suspending a sample in a liquid, such as water or an aqueous 
buffer. The sample source can be a surface Swab; for example, 
a surface can be swabbed; the swab washed by a liquid; 
thereby transferring an analyte from the Surface into the liq 
uid. The sample source can be air; for example, the air can be 
filtered; the filter washed by a liquid; thereby transferring an 
analyte from the air into the liquid. 
The term “sample matrix. as used herein, refers to every 
thing in the sample with the exception of the analyte. 
The term “magnetic field source, as used herein, includes 
permanent magnets and electromagnets, which are separate, 
individual entities with defined N-S magnetic poles. A 
"dipole magnet comprises one magnetic field source. 
The term "sandwich magnet, as used herein, refers to 
magnets comprising two or more magnetic field sources con 
figured such that their opposing magnetic fields overlap or are 
coerced. This can be accomplished by placing opposing poles 
(N-Nor S-S) in closer proximity to each other than the attract 
ing poles (N-S) of the magnetic fields sources. For example, 
two dipole magnets arranged in a N-S-S-N or a S-N-N-S 
configuration would form a sandwich magnet. 
The term “channel magnet, as used herein, refers to a 
single magnetic field source bonded to a highly magnetizable 
material in the form of a U-shaped channel. In such a con 
figuration, the magnetizable material becomes an extension 
of the magnetic pole to which it is bound. 
B. ECL Moieties 
The term “ECL moiety” refers to an electrochemilumines 
cent moiety, which is any compound that can be induced to 
repeatedly emit electromagnetic radiation by exposure to an 
electrical energy source. Representative ECL moieties are 
described in Electrogenerated Chemiluminescence, Bard, 
Editor, Marcel Dekker, (2004); Knight, A and Greenway, G. 
Analyst 119:879-890 1994; and in U.S. Pat. Nos. 5.221,605; 
5,591,581; 5,858,676; and 6,808.939. Preparation of primers 
comprising ECL moieties is well known in the art, as 
described, for example, in U.S. Pat. No. 6,174,709. Some 
ECL moieties emit electromagnetic radiation is the visible 
spectrum while other might emit other types of electromag 
netic radiation, such as infrared or ultraviolet light, X-rays, 
microwaves, etc. Use of the terms "electrochemilumines 
cence', 'electrochemiluminescent”, “electrochemilumi 
nesce”, “luminescence”, “luminescent and “luminesce' in 
connection with the present invention does not require that 
the emission be light, but includes the emission being Such 
other forms of electromagnetic radiation. 
ECL moieties can be transition metals. For example, the 
ECL moiety can comprise a metal-containing organic com 
pound wherein the metal can be chosen, for example, from 
ruthenium, osmium, rhenium, iridium, rhodium, platinum, 
palladium, molybdenum, and technetium. For example, the 
metal can be ruthenium or osmium. For example, the ECL 
moiety can be a ruthenium chelate or an osmium chelate. For 













ruthenium(II) and tris(2,2'-bipyridyl)ruthenium(II). For 
example, the ECL moiety can be ruthenium (II) tris bipyri 
dine (Ru(bpy)"). The metal can also be chosen, for 
example, from rare earth metals, including but not limited to 
cerium, dysprosium, erbium, europium, gadolinium, hol 
mium, lanthanum, lutetium, neodymium, praseodymium, 
promethium, terbium, thulium, and ytterbium. For example, 
the metal can be cerium, europium, terbium, or ytterbium. 
Metal-containing ECL moieties can have the formula 
wherein M is a metal; P is a polydentate ligand of M: L1, L2. 
L3, L4, L5 and L6 are ligands of M, each of which can be the 
same as, or different from, each other, m is an integer equal to 
or greater than 1; each of n, o, p, q, r and S is an integer equal 
to or greater than Zero; and P. L1, L2, L3, L4, L5 and L6 are 
of such composition and number that the ECL moiety can be 
induced to emit electromagnetic radiation and the total num 
ber of bonds to M provided by the ligands of M equals the 
coordination number of M. For example, M can be ruthe 
nium. Alternatively, M can be osmium. 
Some examples of the ECL moiety can have one polyden 
tate ligand of M. The ECL moiety can also have more than one 
polydentate ligand. In examples comprising more than one 
polydentate ligand of M, the polydentate ligands can be the 
same or different. Polydentate ligands can be aromatic or 
aliphatic ligands. Suitable aromatic polydentate ligands can 
be aromatic heterocyclic ligands and can be nitrogen-contain 
ing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, 
1.10 phenanthroline, and porphyrins. 
Suitable polydentate ligands can be unsubstituted, or sub 
stituted by any of a large number of substituents known to the 
art. Suitable substituents include, but are not limited to, alkyl, 
substituted alkyl, aryl, substituted aryl, aralkyl, substituted 
aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, 
amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, 
amidine, guanidinium, ureide, maleimide Sulfur-containing 
groups, phosphorus-containing groups, and the carboxylate 
ester of N-hydroxysuccinimide. 
In some embodiments, at least one of L1, L2, L3, L4, L5 
and L6 can be a polydentate aromatic heterocyclic ligand. In 
various embodiments, at least one of these polydentate aro 
matic heterocyclic ligands can contain nitrogen. Suitable 
polydentate ligands can be, but are not limited to, bipyridyl, 
bipyrazyl, terpyridyl, 1.10 phenanthroline, a porphyrin, Sub 
stituted bipyridyl, substituted bipyrazyl, substituted terpy 
ridyl, substituted 1,10 phenanthroline or a substituted por 
phyrin. These substituted polydentate ligands can be 
substituted with an alkyl, substituted alkyl, aryl, substituted 
aryl, aralkyl, Substituted aralkyl, carboxylate, carboxalde 
hyde, carboxamide, cyano, amino, hydroxy, imino, hydroxy 
carbonyl, aminocarbonyl, amidine, guanidinium, ureide, 
maleimide a Sulfur-containing group, a phosphorus-contain 
ing group or the carboxylate ester of N-hydroxysuccinimide. 
Some ECL moieties can contain two bidentate ligands, 
each of which can be bipyridyl, bipyrazyl, terpyridyl, 1,10 
phenanthroline, substituted bipyridyl, substituted bipyrazyl, 
substituted terpyridyl or substituted 1,10 phenanthroline. 
Some ECL moieties can contain three bidentate ligands, 
each of which can be bipyridyl, bipyrazyl, terpyridyl, 1.10 
phenanthroline, substituted bipyridyl, substituted bipyrazyl, 
substituted terpyridyl or substituted 1,10-phenanthroline. For 
example, the ECL moiety can comprise ruthenium, two 
bidentate bipyridyl ligands, and one substituted bidentate 
bipyridylligand. For example, the ECL moiety can contain a 
tetradentate ligand Such as a porphyrin or Substituted porphy 
1. 
US 8,840,774 B2 
13 
In some embodiments, the ECL moiety can have one or 
more monodentate ligands, a wide variety of which are 
known to the art. Suitable monodentate ligands can be, for 
example, carbon monoxide, cyanides, isocyanides, halides, 
and aliphatic, aromatic and heterocyclic phosphines, amines, 
Stibines, and arsines. 
In Some embodiments, one or more of the ligands of M can 
be attached to additional chemical labels, such as, for 
example, radioactive isotopes, fluorescent components, or 
additional luminescent ruthenium- or osmium-containing 
CenterS. 
For example, the ECL moiety can be tris(2,2'-bipyridyl) 
ruthenium(II) tetrakis(pentafluorophenyl)borate. For 
example, the ECL moiety can be bis(4,4'-carbomethoxy)-2, 
2'-bipyridine|2-3-(4-methyl-2,2'-bipyridine-4-yl)propyl-1, 
3-dioxolane ruthenium(II). For example, the ECL moiety can 
be bis(2.2 bipyridine) 4-(butan-1-al)-4'-methyl-2,2'-bipyri 
dineruthenium (II). For example, the ECL moiety can be 
bis(2,2'-bipyridine) 4-(4-methyl-2,2'-bipyridine-4-yl)-bu 
tyric acid ruthenium (II). For example, the ECL moiety can 
be (2,2'-bipyridine) cis-bis(1,2-diphenylphosphino)ethyl 
ene{2-3-(4-methyl-2,2'-bipyridine-4-yl)propyl-1,3- 
dioxolaneosmium (II). For example, the ECL moiety can be 
bis(2,2'-bipyridine) 4-(4-methyl-2,2'-bipyridine)-buty 
lamineruthenium (II). For example, the ECL moiety can be 
bis(2,2'-bipyridine) 1-bromo-4-(4-methyl-2,2'-bipyridine-4- 
yl)butaneruthenium (II). For example, the ECL moiety can 
be bis(2,2'-bipyridine)maleimidohexanoic acid, 4-methyl-2, 
2'-bipyridine-4'-butylamide ruthenium (II). 
In some embodiments of the present invention, an assay 
performance-substance is used, wherein the assay-perfor 
mance-substance comprises (i) an ECL moiety and (ii) a 
labeled binding partner for an analyte or a labeled analog of 
the analyte. 
In some embodiments of the present invention, the assay 
performance-substance comprises an ECL moiety. 
In some embodiments, the ECL moiety comprises a metal 
ion selected from osmium and ruthenium. 
In some embodiments, the ECL moiety comprises a deriva 
tive of trisbipyridyl ruthenium (II) Ru(bpy)"). 
In some embodiments, the ECL moiety can be Ru(sulfo 
bpy).bpy" whose structure is 
SONa 
NaOS 
wherein W is a functional group such as an NHS ester, an 
activated carboxyl, an amino group, a hydroxyl group, a 













midite. This functional group can react with a biological 
material, binding reagent, enzyme Substrate or other assay 
reagent to form a covalent linkage. 
In some embodiments, the ECL moiety does not comprise 
a metal. Such non-metal ECL moieties can be, but are not 
limited to, rubrene and 9,10-diphenylanthracene. 
C. ECL Coreactant 
The tem “ECL coreactant, as used herein, pertains to a 
chemical compound that either by itself or via its electro 
chemical reduction oxidation product(s), plays a role in the 
ECL reaction sequence. For simplicity, as used herein, ECL 
coreactants are described without regard to acid-base reac 
tions; all acid-base forms of the stated compounds are also 
contemplated and claimed. 
Often ECL coreactants can permit the use of simpler means 
for generating ECL (e.g., the use of only half of the double 
step oxidation-reduction cycle) and/or improved ECL inten 
sity. In some embodiments, ECL coreactants can be chemical 
compounds which, upon electrochemical oxidation/reduc 
tion, yield, directly or upon further reaction, strong oxidizing 
or reducing species in Solution. An ECL coreactant can be 
peroxodisulfate (i.e., S.O., persulfate) which is irreversibly 
electro-reduced to form oxidizing SO ions. The ECL core 
actant can also be oxalate (i.e., C.O.) which is irreversibly 
electro-oxidized to form reducing CO. ions. A class of ECL 
coreactants that can act as reducing agents is amines or com 
pounds containing amine groups, including, for example, 
tri-n-propylamine (i.e., N(CH2CHCH), TPA). In some 
embodiments, tertiary amines can be better ECL coreactants 
than secondary amines. In some embodiments, secondary 
amines can be better ECL coreactants than primary amines. 
In some embodiments, the electrochemical cell of the 
present invention further comprises an ECL coreactant. 
In some embodiments, the ECL coreactant comprises a 
tertiary amine. 
In some embodiments, the ECL coreactant comprises a 
tertiary amine comprising a hydrophilic functional group. 
In some embodiments, the ECL coreactant is an amine 
having a structure NRRR, wherein R, R and Rare C. 
aliphatic groups wherein at least one of the Coaliphatic 
groups is substituted with at least one hydrophilic functional 
group. In some embodiments, the hydrophilic functional 
group is a charged group, for example, a negatively charged 
group. Hydrophilic functional groups can be hydroxyl, 
hydroxycarbonyl, amino, aminocarbonyl, amidine, imino, 
cyano, nitro, nitrate, Sulfate, Sulfonate, phosphate, phospho 
nate, silicate, carboxylate, borate (B(OH)), guanidinium, 
carbamide, carbamate, carbonate, Sulfamide, silyl, siloxy, 
and amide. 
In some embodiments, the ECL coreactant has the struc 
ture (n-propyl)N(CH), R*: wherein n1 is an integer from 1 
to 10; and R* is a hydrophilic functional group, as defined 
above. In some embodiments, n1 is 2. In some embodiments, 
n1 is 3. In some embodiments, n1 is 4. 





wherein X is selected from —(CH) , —(CHR') , 
—(CR'R'')—, a heteroatom, and —N(R') : R is a Co 
aliphatic group Substituted with at least one hydrophilic func 
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tional group; each of R'' and R' is independently a Co 
aliphatic group optionally Substituted with at least one hydro 
philic functional group; and n and mare independently inte 
gers from 1 to 10. 
In some embodiments, the heteroatom can be, for example, 
—O— or —S—. 
In some embodiments, n is 2. In some embodiments, n is 3. 
In some embodiments, n is 4. In some embodiments, m is 2. 
In some embodiments, m is 3. In some embodiments, m is 4. 
In some embodiments, R'' is a Caliphatic group. 
In some embodiments, R is a Caliphatic group Substi 
tuted with at least one hydrophilic functional group. 
When X is N(R') , R' can be, for example, 
—(CH2), R', whereining is an integer from 3 to 20, or, for 
example, from 3 to 10, and R' is H, an aliphatic group, or a 
hydrophilic functional group. In some embodiments n3 is 3. 
In some embodiments n3 is 4. 
In some embodiments, Ris-(CH2)2 R', wherein n2 is 
an integer from 3 to 20, for example 3 to 10. 
In some embodiments n2 is 3. In some embodiments n2 is 
4. In some embodiments n2 is 5. 
In some embodiments, R' is a hydrophilic functional 
group. In some embodiments R'' is a carboxylate or Sul 
fonate. 
The use of ECL coreactants having hydrophilic functional 
groups (and, in particular, ECL coreactants that are Zwitteri 
onic at neutral pH) has a variety of advantages that are unre 
lated to their ability to act as ECL coreactants. These species 
tend to be highly water soluble and to have low vapor pres 
Sure. For these reasons it is possible to produce highly con 
centrated Stock solutions that may be diluted as necessary for 
use. It is also possible to prepare dried reagents comprising 
the ECL coreactants without uncertainty due to loss of ECL 
coreactant in the vapor phase. Furthermore, when present in a 
dry composition, these ECL coreactants resolubilize quickly 
in a minimum of Volume. 
ECL coreactants include, but are not limited to, lincomy 
cin; clindamycin-2-phosphate, erythromycin; 1-methylpyr 
rolidone; diphenidol; atropine; trazodone; hydroflumethiaz 
ide; hydrochlorothiazide; clindamycin; tetracycline; 
streptomycin; gentamicin; reserpine; trimethylamine; tri-n- 
butylphosphine; piperidine; N.N-dimethylaniline; phe 
niramine; bromopheniramine; chloropheniramine; diphenyl 
hydramine; 2-dimethylaminopyridine; pyrilamine; 
2-benzylaminopyridine; leucine; Valine; glutamic acid; phe 
nylalanine; alanine; arginine; histidine; cysteine; tryptophan; 
tyrosine; hydroxyproline; asparagine; methionine; threonine; 
serine; cyclothiazide; trichlormethiazide; 1,3-diaminopro 
pane; piperazine, chlorothiazide, barbituric acid; persulfate; 
penicillin: 1-piperidinyl ethanol; 1,4-diaminobutane; 1,5-di 
aminopentane; 1,6-diaminohexane; ethylenediamine; benze 
nesulfonamide, tetramethylsulfone; ethylamine; n-hexy 
lamine; hydrazine Sulfate; glucose; n-methylacetamide; 
phosphonoacetic acid; and/or salts thereof 
ECL coreactants include, but are not limited to, 1-ethylpi 
peridine; 2.2-Bis(hydroxymethyl)-2,2'2"-nitrilotriethanol 
(BIS-TRIS); 1,3-bis(tris(hydroxymethyl)methylaminopro 
pane (bis-Tris propane) (BIS-TRIS propane); 2-Morpholino 
ethanesulfonic acid (MES); 3-(N-Morpholino)propane 
sulfonic acid (MOPS): 3-Morpholino-2- 
hydroxypropanesulfonic acid (MOPSO); 4-(2- 
Hydroxyethyl)piperazine-1-(2-hydroxypropanesulfonic 
acid) (HEPPSO): 4-(2-Hydroxyethyl)piperazine-1-propane 
sulfonic acid (EPPS): 4-(N-Morpholino)butanesulfonic acid 
(MOBS); N,N-Bis(2-hydroxyethyl)glycine (BICINE): 
DAB-AM-16, Polypropylenimine hexadecaamine Den 













dotriacontaamine Dendrimer (DAB-AM-32); DAB-AM-4, 
Polypropylenimine tetraamine Dendrimer (DAB-AM-4); 
DAB-AM-64, Polypropylenimine tetrahexacontaamine Den 
drimer; DAB-AM-8, Polypropylenimine octaamine Den 
drimer (DAB-AM-8); di-ethylamine; dihydronicotinamide 
adenine dinucleotide (NADH); di-iso-butylamine; di-iso 
propylamine; di-n-butylamine; di-n-pentylamine; di-n-pro 
pylamine; di-n-propylamine; ethylenediamine tetraacetic 
acid (EDTA); Glycyl-glycine (Gly-Gly); N-(2-Acetamido) 
iminodiacetic acid (ADA); N-(2-Hydroxyethyl)piperazine 
N'-(2-ethanesulfonic acid) (HEPES); N-(2-Hydroxyethyl) 
piperazine-N'-(4-butanesulfonic acid) (HEPBS); N,N-Bis(2- 
hydroxyethyl)-3-amino-2-hydroxypropanesulfonic acid (D 
IPSO); N,N-Bis(2-hydroxyethyl)taurine (BES); N-ethylmor 
pholine; oxalic acid, Piperazine-1,4-bis(2-hydroxypropane 
sulfonic acid) (POPSO); S-butylamine; sparteine; t-buty 
lamine; triethanolamine; tri-ethylamine; tri-iso-butylamine; 
tri-iso-propylamine; tri-n-butylamine; tri-n-butylamine; tri 
n-pentylamine; N.N.N',N'-Tetrapropyl-1,3-diaminopropane: 
oxalate; peroxodisulfate; piperazine-1,4-bis(2-ethane 
sulfonic acid) (PIPES); tri-n-propylamine: 3-dimethylamino 
1-propanol: 3-dimethylamino-2-propanol; 1,3-Bis(dimethy 
lamino)-2-propanol; 1,3-Bis(diethylamino)-2-propanol; 1,3- 
Bis(dipropylamino)-2-propanol: N-tris(hydroxymethyl) 
methyl-2-aminoethane sulfonic acid (TES); piperazine-N,N'- 
bis-3-propanesulfonic acid (PIPPS); piperazine-N,N'-bis-4- 
butanesulfonic acid (PIPBS); 1,6-diaminohexane-N,N,N',N'- 
tetraacetic acid, 4-(di-n-propylamino)-butanesulfonic acid; 
4-bis-(2-hydroxyethane)-amino-butanesulfonic acid; 
azepane-N-(3-propanesulfonic acid); N,N-bis propyl-N-4- 
aminobutanesulfonic acid; piperazine-N,N'-bis-3-methyl 
propanoate; piperazine-N-2-hydroxyethane-N-3-methyl 
propanoate; piperidine-N-(3-propanesulfonic acid); 
piperidine-N-(3-propionic acid) (PPA): 3-(di-n-propy 
lamino)-propanesulfonic acid; and/or salts thereof. 
In some embodiments, the ECL coreactant is selected from 
piperazine-1,4-bis(2-ethanesulfonic acid) (PIPES), tri-n-pro 
pylamine, N.N.N',N'-Tetrapropyl-1,3-diaminopropane, 1,3- 
Bis(dipropylamino)-2-propanol, and salts and mixtures 
thereof. 
In some embodiments, the ECL coreactant is selected from 
oxalate or tri-n-propylamine. 
D. Electrochemical Cells and Electrodes 
The term “half-cell refers to half of an electrolytic or 
voltaic cell, where either oxidation or reduction occurs. 
The term "half-cell reaction” refers the reaction that occurs 
when electrons are exchanged between an electrode in the 
half-cell and the electrolyte. At the anode the half-cell reac 
tion is oxidation, while the half-cell reaction at the cathode is 
reduction. 
The term “half-cell product” refers the products formed 
from a half-cell reaction. 
The term “working electrode' refers to the test or specimen 
electrode in an electrochemical cell where one half-cell reac 
tion takes place. In the present instance the working electrode 
is also a faradaic electrode. 
The term “counter electrode” refers to an electrode in an 
electrochemical cell to which charge flows, which charge is 
necessarily of an opposite sign to that charge that flows to the 
working electrode. In some embodiments the counter elec 
trode is also a capacitive electrode. 
The term “reference electrode” refers to a nonpolarizable 
electrode with a known and highly reproducible potential 
used for potentiometric and Voltammetric analyses. The ref 
erence electrode provides a stable reference point, against 
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which the Voltage of a working electrode is measured. Typical 
reference electrodes are the silver/silver chloride electrode 
and the calomel electrode. High stability of the potential of 
the reference electrode is achieved by employing an oxida 
tion-reduction system where all participants (usually two, an 
oxidant and reductant) of the reaction are present at high 
concentrations. During use no significant current is passed so 
as to alter the concentration of oxidant or reductant. A refer 
ence electrode (RE) differs from a faradaic electrode. 
The term “faradaic electrode” refers to an electrode that 
generally obeys Faradays law while being used in an elec 
trochemical cell. Faradaic electrodes exclude reference elec 
trodes. A faradaic electrode allows significant current to pass 
which can alter the concentration Some or all of the oxidation 
reduction participants. For example, a faradaic electrode may 
operate on a system where only the oxidant is initially present 
So as to form a reductant. For example, a faradaic electrode 
may operate on a system where only the reductant is initially 
present so as to form a oxidant. 
Faradaic electrodes can be made from metals and semicon 
ductors, such as platinum sheet electrodes, platinum wire 
electrodes, platinum alloy electrodes (including alloying ele 
ments Ni, Pd, Au, Co, Fe, Ru, Os, Cr, Mo, Zr, Nb, Ir, Rh, and 
W), iridium electrodes, iridium alloy electrodes (including 
alloying elements Ni, Pd, Co, Fe, Ru, Os, Cr, Mo, Zr, Nb, Pt, 
Rh, and W), rhodium electrodes, rhodium alloy electrodes 
(including alloying elements Au, Ni, Pd, Co, Fe, Ru, Os, Cr, 
Mo, Zr, Nb, Ir, Pt, and W), glassy carbon electrodes, graphite 
electrodes, carbon electrodes, carbon ink electrodes, gold 
electrodes, silver electrodes, silver alloy electrodes, nickel 
electrodes, nickel alloy electrodes, stainless steel working 
electrodes, and the like. See, for example, Bard and Faulkner; 
Wiley, Electrochemical Methods. Fundamentals and Appli 
cations: 2 ed (2000). 
In some embodiments of the present invention, the faradaic 
working electrode comprises carbon, gold, gold alloys, plati 
num, platinum alloys, iridium, iridium alloys, silver, sliver 
alloys, nickel, nickel alloys, stainless steel, or mercury. 
In some embodiments, the faradaic working electrode is an 
ultramicroelectrode. 
The term “capacitive electrode” refers to an electrode that 
has limited electron transfer to the electrolyte solution. The 
capacitive electrode is characterized by an ability to build up 
or trap charge within the electrode. The charge trapped within 
the electrode is stabilized by the build-up or collection of 
ionic species (a so-called double layer) in the electrolyte at the 
electrode surface/electrolyte interface. An electrode may be 
considered to be a capacitive electrode even if some galvanic 
current is measurable. 
One method to characterize a capacitive electrode is via the 
amount of galvanic current per unit area that can pass through 
the electrode. This current is sometimes referred to as a “leak 
age current density'. For the sake of clarity, the leakage 
current is measured using the following method. 1. Use a cell 
containing (a) the test electrode with geometric area of 0.1 
cm, (b) a silver/silver chloride reference electrode whose 
electrochemical area is at least 10 times the test electrode area 
and wherein the separation between the electrodes is less than 
the largest dimension of the reference electrode, and (c) an 
inert supporting electrolyte: aqueous 3 M KC1, pH 6 to 8 
(adjusted with HCl or KOH). Apply voltage that steps from 
the rest potential (the potential at which no current flows) to 
the rest potential plus 0.32 V. Measure the current as a func 
tion of time. The experiment-1-time-constant is the absolute 
value of the ratio of the current and the slope at the time at 
which the slope of the current decay is greatest. 2. Using same 













final concentration of each is 1 mM, provide sufficient solu 
tion stirring Such that the stirred cell has a mass transfer 
coefficient of 10° cm/s, use a total solution volume such that 
the Volume is greater than or equal to the test electrode area 
multiplied by mass transfer coefficient multiplied by experi 
ment-1-time-constant multiplied by 100, then apply same 
voltage waveform as step 1. The “leakage current is defined 
as the current measured in this second step after 25 experi 
ment-1-time-constants. The leakage current density is the 
defined as the leakage current divided by the test electrode 
aca. 
In some embodiments, a capacitive electrode is one whose 
leakage current density is less than 10 JLA/cm. In some 
embodiments, a capacitive electrode is one whose leakage 
current density is less than 1 JLA/cm. In some embodiments, 
a capacitive electrode is one whose leakage current density is 
less than 100 na/cm. In some embodiments, a capacitive 
electrode is one whose leakage current density is less than 10 
nA/cm. In some embodiments, a capacitive electrode is one 
whose leakage current density is less than 1 nA/cm. In some 
embodiments, a capacitive electrode is one whose leakage 
current density is less than 100 pA/cm. In some embodi 
ments, a capacitive electrode is one whose leakage current 
density is from about 100 pA/cm to about 10 JLA/cm. In 
Some embodiments, a capacitive electrode is one whose leak 
age current density is from about 1 nA/cm to about 1 
LA/cm. 
One method to characterize a capacitive electrode is via the 
electrode's time constant. The time constant is defined as the 
product of the electrode resistance and electrode capacitance. 
The following apparatus is used to measure these quantities 
(which is intended to minimize the impedance of the solution 
and a non-test electrode in order to better ascertain the prop 
erties of a test electrode): (1) a cell containing the test elec 
trode and an Ag/AgCl electrode whose electrochemical area 
is at least 10 times the area of the test electrode wherein the 
separation between the electrodes is less than the largest 
dimension of the reference electrode; (2) an aqueous solution 
in the cell consisting essentially of 760 uM KFe(CN), 760 
uM KFe(CN), and 1 M KC1, pH 6-8 (adjusted with KOH 
and/or HCl); and (3) a voltage generator that applies a DC 
bias Voltage equal to the rest potential (the potential at which 
the current is 0) plus a 59 mV peak sinusoid and a current 
meter. A Swept sine technique is used to measure the fre 
quency dependence of the complex impedance (applied Volt 
age divided by measured current). Let Z1 equal the asymp 
totic value of the magnitude of the complex impedance as the 
frequency approaches 0. Let Z2 equal the asymptotic value of 
the magnitude of the complex impedance in the high fre 
quency limit. Letco, equal the radian frequency at which the 
phase angle of the complex impedance is the most negative. 
The electrode resistance equals Z1-Z2. The electrode capaci 
tance equals 
W31 fa2 
(31 - 32)coin 
In some embodiments, a capacitive electrode is one whose 
time constant is greater than or equal to 1 second. In some 
embodiments, a capacitive electrode is one whose time con 
stant is greater than or equal to 10 seconds. In some embodi 
ments, a capacitive electrode is one whose time constant is 
greater than or equal to 100 seconds. In some embodiments, 
a capacitive electrode is one whose time constant is greater 
than or equal to 1,000 seconds. In some embodiments, a 
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capacitive electrode is one whose time constant is greater than 
or equal to 10,000 seconds. In some embodiments, a capaci 
tive electrode is one whose time constant is from about 1 
second to about 100,000 seconds. In some embodiments, a 
capacitive electrode is one whose time constant is from about 
5 seconds to about 10,000 seconds. In some embodiments, a 
capacitive electrode is one whose time constant is from about 
10 seconds to about 1,000 seconds. In some embodiments, a 
capacitive electrode is one whose time constant is from about 
10 seconds to about 100 seconds. 
One method to characterize a capacitive electrode is by the 
ratio of the time constants of the capacitive electrode and the 
working electrode. This ratio is related to the ratio of the 
amount of electrochemical product generated at the two elec 
trodes. Typically, as the time constant of the capacitive elec 
trode increases relative to the working electrode, the amount 
of electrochemical product generated at the capacitive elec 
trode relative to the working electrode decreases. In this defi 
nition, a capacitive electrode cannot be defined in isolation; 
rather it is defined relative to a particular working electrode. 
To compute the ratio of the time constants of the capacitive 
electrode and the working electrode, each time constant is 
measured individually using the method described in the 
previous paragraph. In some embodiments, a capacitive elec 
trode is one whose time constant is 10 times larger than the 
time constant of the working electrode. In some embodi 
ments, a capacitive electrode is one whose time constant is 
100 times larger than the time constant of the working elec 
trode. In some embodiments, a capacitive electrode is one 
whose time constant is 1,000 times larger than the time con 
stant of the working electrode. In some embodiments, a 
capacitive electrode is one whose time constant is 10,000 
times larger than the time constant of the working electrode. 
In some embodiments, the capacitive counter electrode is 
an ideally polarized electrode. 
In some embodiments, the capacitive counter electrode 
comprises a semiconductive material with an oxide layer. 
In some embodiments, the capacitive counter electrode 
comprises a conductive material with an oxide layer. 
In some embodiments, the capacitive counter electrode 
comprises a material whose bulk resistivity is less than about 
10° S.2m at 20° C., covered by an electrically insulating 
material having a bulk resistivity greater than 10 S2m at 20° 
C. wherein the insulating material has a meanthickness that is 
less than about 1 Lum. 
In some embodiments, the insulating material has a bulk 
resistivity greater than 10 S2m at about 20° C. and the insu 
lating material has a meanthickness that is less than about 100 
. 
In some embodiments, the capacitive counter electrode 
comprises oxides of silicon, titanium, aluminum, magne 
sium, Zirconium, and/ortantalum. 
The term “electrolyte' refers to a medium that provides the 
ion transport mechanism between the electrodes of an elec 
trochemical cell. Generally electrolytes are substances that 
dissociates into ions when in Solution and are capable of 
conducting electricity, Such as acids, bases, and salts. 
The term “capacitance” refers to that property which per 
mits the storage of electrically separated charges when poten 
tial differences exist between conductors. The capacitance of 
a two-terminal capacitor is defined as the ratio between the 
electric charge ohmically connected to one terminal and the 
resultant difference in potential between the terminals. In the 
present invention the capacitive electrode acts like a capacitor 
when it stores charge within the electrode and collects counter 













The term “permittivity” equals to the electric flux density 
(D) divided by the electric field strength (E). The permittivity 
of a material can change with frequency. In these electro 
chemical applications, the relevant frequency range is low, 
with the upper end rarely exceeding 10's of kHz. The capaci 
tance of a parallel plate capacitor is approximately equal to 
the permittivity of the material between the plates multiplied 
by the area of one of the plates divided by distance between 
the plates. 
"Coulometric methods' are known in the art and can be 
used to quantitatively add electrons to or remove electrons 
from a system. Coulometric methods involve electrochemical 
generation of chemical species in a solution via an electrode 
reaction. The amount of product (N) generated at the fara 
daic working electrode can be controlled by the charge passed 
at that electrode, as governed by Faraday's law: N-q/(nF) 
where q is the charge passing through the electrode, n is the 
number of electrons used to generate 1 molecule of product at 
the working electrode, and F is Faraday's constant. When 
using coulometric methods, care must be taken to account for 
the electrode's capacitance. 
Capacitive electrodes can be made from oxidized metals 
and semiconductors. Further examples of capacitive elec 
trodes include electrodes made from materials having a bulk 
resistivity less than 10 S2/m at 20° C., covered by a thin 
(mean thickness less than 10 um) insulating material, includ 
ing dielectrics for integrated circuit fabrication Such as silicon 
dioxide, silicon nitride, TiN, TaN, TiAlN, TaAlN, TaSiN, 
SrTiO, Ta-Os, TiO, YO, ZrO, Hf, Al-O, BaSrTiO, 
FOXR-1X and FOXR-2x (Dow Corning, Midland, Mich.) 
flowable oxide product families (comprising hydrogen sils 
esquioxane); solder masks (as described in the standard IPC 
SM-840C: Qualification and performance of permanent sol 
der mask); and conformal coatings (as described in the stand 
IPC-SM-840 Qualification and Performance of Permanent 
Solder Mask) such as parylene and NovecTM EGC-1700, 
EGC-1702, EGC-1704, and EGC-1720 electronic coatings 
(3M, MN). 
Further examples of capacitive electrodes include elec 
trodes made from materials having a bulk resistivity less than 
10° S.2m at 20°C., covered by a thin (meanthickness less than 
1 um) insulating material Such as oxides of silicon, titanium, 
aluminum, magnesium, Zirconium, and/or tantalum. 
Further examples of capacitive electrodes include elec 
trodes made from materials having a bulk resistivity less than 
10° S.2m at 20°C., covered by a thin (meanthickness less than 
1 um) insulating material deposited by chemical vapor depo 
sition or by spin coating. 
Further examples of capacitive electrodes include elec 
trodes made from materials having a bulk resistivity less than 
10° S.2m at 20°C., covered by a thin (meanthickness less than 
1 um) insulating material having a bulk resistivity greater than 
10 S2m at 20° C. Thinner insulating layers can provide 
increased capacitance for a given electrode area; however, 
thinner insulating layers may cause increased leakage cur 
rents through the presence of pin-holes in the insulation or by 
dielectric breakdown. In some embodiments, the mean thick 
ness of the insulating layer on the capacitive electrode is less 
than 10 um. In some embodiments, the mean thickness of the 
insulating layer on the capacitive electrode is less than 1 Jum. 
In some embodiments, the mean thickness of the insulating 
layer on the capacitive electrode is less than 100 nm. In some 
embodiments, the mean thickness of the insulating layer on 
the capacitive electrode is less than 10 nm. In some embodi 
ments, the mean thickness of the insulating layer on the 
capacitive electrode is less than 1 nm. In some embodiments, 
the mean thickness of the insulating layer on the capacitive 
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electrode is from about 1 nm to about 10um. In some embodi 
ments, the mean thickness of the insulating layer on the 
capacitive electrode is from about 10 nm to about 1 Lum. In 
Some embodiments, the mean thickness of the insulating 
layer on the capacitive electrode is from about 10 nm to about 
100 nm. 
The capacitance of a capacitive electrode increases with 
the permittivity of the insulating layer. In some embodiments, 
the insulating layer has a permittivity that is about equal to the 
permittivity of free space. In some embodiments, the insulat 
ing layer has a permittivity that is greater than about 1 times 
and less than about 3 times the permittivity of free space. In 
Some embodiments, the insulating layer has a permittivity 
that is greater than about 3 times and less than about 5 times 
the permittivity of free space. In some embodiments, the 
insulating layer has a permittivity that is greater than about 5 
times and less than about 10 times the permittivity of free 
space. In some embodiments, the insulating layer has a per 
mittivity that is greater than about 10 times and less than 
about 100 times the permittivity of free space. In some 
embodiments, the insulating layer has a permittivity that is 
greater than about 100 times the permittivity of free space. 
II. CERTAIN EMBODIMENTS OF THE CELL 
AND ELECTRODES 
The present invention is directed to methods and apparatus 
utilizing an electrochemical cell comprising a faradaic work 
ing electrode and a capacitive counter electrode. The capaci 
tive counter electrode can be characterized by, for example, 
its leakage current density, its time constant, and the ratio of 
its time constant to the working electrode's time constant, or 
combinations thereof. In some embodiments the electro 
chemical apparatus is operated in a manner that allows a 
constant faradaic current at the working electrode while pro 
ducing little to no oxidation or reduction products at the 
counter electrode. In some embodiments the electrochemical 
apparatus is operated in a manner that allows a constant 
faradaic current at the working electrode while reducing the 
amount of oxidation or reduction products at the counter 
electrode. 
Typical electrochemical cells employ faradaic electrodes 
at both the anode (where oxidations occur) and the cathode 
(where reductions occur). A separate half-reaction occurs at 
each of these electrodes, producing a different product (half 
cell product) at each of the electrodes. The solution as a whole 
maintains charge (ionic) neutrality at all times because equal 
charges of anionic and cationic species are generated by each 
of the half-cell reactions at the corresponding electrodes. 
Generally only the reaction or product at the working elec 
trode is of interest. In fact, the counter electrode is often 
placed in a different compartment, separated by an ionically 
conducting “cell-separator' to prevent mixing of the half-cell 
products formed at each of the electrodes. Salt bridges and 
other ionically conducting cell-separators are known in the 
art. See, for example, Bard and Faulkner; Wiley, Electro 
chemical Methods. Fundamentals and Applications: 2 ed 
(2000). 
The present invention can be used in many sizes of elec 
trochemical cells that comprise a faradaic working electrode 
and a capacitive counter electrode. Exemplary size ranges for 
the faradaic working electrode include macroscopic geo 
metrical areas of about 0.1 um to about 10 m, about 10um 
to about 10000 cm, about 10 um to about 100 cm, about 
10000 um to about 10 cm, about 1 mm to about 100 mm, 
and about 1 mm to about 10 mm. Exemplary sizes for the 













areas of about 0.1 um, 1 um, 10 um, 100 m, 1000 um, 
10000 um, 1 mm, 10 mm, 100 mm, 1 cm, 10 cm, 100 
cm, 1000 cm, 10000 cm, 1 m, or 10 m. Exemplary sizes 
and size ranges the capacitive counter electrode include those 
sizes for the faradaic working electrode plus larger sizes to 
accommodate such embodiments as electrode 202. 
In some embodiments, the electrochemical cell can par 
tially enclose a sample Volume. For example, the cell can be 
a well in a multi-well assay plate, a beaker, a tube, a flow cell, 
or other shapes and sizes. In some embodiments, the faradaic 
and the capacitive counter electrode can be in a single cell, for 
example cell 200. In some embodiments, the counter elec 
trode and the working electrode can be in individual cells 
conductively connected to one another by a salt bridge, frit, or 
other bridging means, which are well known in the art. The 
cell can also be configured so that only one of the faradaic 
working electrode and the counter electrode is positioned 
within the cell, and the other is positioned adjacent to the cell, 
but in contact with the fluid within the cell. In addition, the 
cell can be one of a plurality of single or split cells, for 
example, the wells of a multi-well plate or multiple tubes in an 
auto-sampling system. 
The electrochemical cell can also be a flow cell. The flow 
cell can be configured with an inlet and outlet such that the 
fluids can flow through the inlet into the cell and then flow out 
of the cell through the outlet. Exemplary electrochemilumi 
nescence flow cells and methods for their use are disclosed in 
U.S. Pat. No. 6,200,531. 
In some embodiments, the electrochemical cell is capable 
of receiving an electrolyte solution. This solution can partici 
pate in electrochemical reactions at the faradaic working 
electrode when contacted by the faradaic working electrode 
and the capacitive counter electrode in the electrochemical 
cell and electrical energy is applied between the electrodes. 
In some embodiments, the electrochemical cell can further 
comprise a reference electrode. In some embodiments, the 
cell does not comprise a reference electrode. The reference 
electrode, when present, can be used to better control the 
potential drop across the faradaic working electrode irrespec 
tive of the potential drop across the capacitive counter elec 
trode until the Voltage compliance limit of the potentiostat is 
attained or dielectric breakdown occurs at the capacitive 
counter electrode. 
III. CERTAIN EMBODIMENTS OF THE 
APPARATUS 
In Some embodiments, the apparatus can comprise an 
assay-performance-substance comprising at least one of (a) a 
labeled binding partner for an analyte and (b) a labeled analog 
of the analyte. In some embodiments, the assay-performance 
Substance can be a dry composition. In some embodiments, 
the assay-performance-substance comprises an ECL moiety. 
In these embodiments, the apparatus may optionally com 
prise an ECL coreactant. 
In some embodiments, the apparatus further comprises a 
vapor barrier that encloses the assays-performance-Sub 
stance, for example, to prevent evaporation of a liquid com 
position or to prevent melt-back of a dry composition. 
In some embodiments, the apparatus can comprise a filter 
in fluidic connection to the faradaic working electrode and 
capacitive counter electrode. Filtration is one method for 
removing interfering components of the sample matrix. The 
interfering components can be removed from the sample 
matrix prior to the sample entering the electrochemical cell. 
In this approach, the barrier of the filter can retain particulate 
components that might interfere with the detection process. 
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Particulate components of the matrix can, for example, inter 
fere with some of the detection methodologies that require 
capture or deposition of beads on a detection Surface. Addi 
tionally, removing interfering components can decrease the 
amount of Surface that is available to bind analyte. In some 
embodiments, the filter entrapped particulate components 
can be treated to release analyte for the detection process. 
Filtration primarily separates components from Solutions 
by presenting a physical barrier that can exclude particles 
larger than a given size. There are many different methods in 
the filtration art to make barriers of these types, each method 
a function of the base material being manipulated. For 
example, metal wire is commonly used to make woven 
screens that can be used to catch extremely large particles, for 
examples, particles over 50 microns in size. To capture 
smaller airborne particles, smaller diameter metal wire 
screens can be used, but they have limitations due to imped 
ance to air flow (pressure drop). Polymer-based membranes 
are typically used to remove Smaller particles from Solutions. 
For example, the polymer nylon can be used in a phase inver 
sion casting process to make membranes that range from 
about a 10 micron pore size rating, downto about a 0.1 micron 
pore size rating. Other polymer-based membranes (e.g. poly 
etherSulphone, nitrocellulose, or cellulose acetate) can be 
made by a solvent evaporation casting process. The filtration 
medium is generally incorporated into a holding device that 
allows the fluid of interest to pass through the filter barrier in 
a controlled manner. In some embodiments, the invention can 
use a filter-containing filtration media using the polymer 
polyethersulphone (PES). In certain embodiments, the PES 
filter can be encased in a plastic housing that can be (a) 
attached to a syringe, (b) part of a single use disposable 
designed to ease robotic automation, or (c) part of a multiple 
use disposable designed to filter a plurality of samples. 
Filtration primarily separates components from Solutions 
by size. In most filters, the pathway through the filter is not a 
straight hole, but rather a twisted path. This makes describing 
filter hole size somewhat operational in nature, and gives rise 
to the term “Pore Size Rating. In determining a filter's Pore 
Size Rating, filters are challenged with a known volume (or 
amount) of particles of a known size (known by a secondary 
means like microscopy, light scattering, or impedance mea 
Surements). Then, the amount of particles downstream of the 
filter is measured and compared to the amount of particles 
upstream of the filter, across multiple sizes of particles. When 
the ratio of downstream to upstream particles drops signifi 
cantly below unity for a given size range of particles, the filter 
is said to have removal capacity for that size range. These 
ratios are typically described in logarithmic-based units of 
removal. For example, a filter rated at 5 microns will typically 
reduce the level of downstream particles greater than 5 
microns by a ratio of 0.90 (90% removal or 1 log removal) to 
a ratio of 0.999 (99.9% removal: or 3 log removal). The pore 
size of the filter can be chosen based many factors. In some 
embodiments, the pore size can be large enough to pass the 
analyte, for example, anthrax spores, which are approxi 
mately 1 um in size. In certain embodiments, the pore size can 
be small enough to block interfering components from the 
sample matrix. The pore size can also affect the rate of fluid 
flow across the filter, with Smaller pores generally creating 
larger resistances to flow. 
In some embodiments, the filter has a pore size rating of 5 
microns. In some embodiments, the filter has a pore size 
rating of 0.1, 0.2,0.5, 1, 2, 3, 4, 7, 10, 15, 20, 50, or 100 
microns. In some embodiments, the filter has a pore size 
rating less than or equal to about 100 microns and greater than 













has a pore size rating less than or equal to about 10 microns 
and greater than or equal to about 1 microns. In some embodi 
ments, the filter has a pore size rating less than or equal to 
about 1 microns and greater than or equal to about 0.1 
microns. In some embodiments, the filter has a pore size 
rating less than or equal to about 0.1 microns and greater than 
or equal to about 0.02 microns. 
In Some embodiments, the apparatus comprises (a) an elec 
trochemical cell comprising a faradaic working electrode and 
a capacitive counter electrode wherein the electrochemical 
cell is capable of receiving an electrolyte solution; and (b) any 
combination of the reference electrode, an assay-perfor 
mance-substance comprising at least one of (i) a labeled 
binding partner for an analyte and (ii) a labeled analog of the 
analyte, the ECL coreactant, and the filter. In certain embodi 
ments, the apparatus is an expendable or replaceable element 
in a larger instrument, for example, to prevent the larger 
instrument from contacting the electrolyte solution (which 
may contain a sample comprising an analyte that is desired to 
be detected). In certain of these embodiments, the apparatus 
comprises the assay-performance-substance in a dry compo 
sition and a vapor barrier that encloses the assay-perfor 
mance-substance. 
In some embodiments, the apparatus comprises any of the 
above embodiments (for example, an apparatus comprising 
an electrochemical cell comprising a faradaic working elec 
trode and a capacitive counter electrode wherein the electro 
chemical cell is capable of receiving an electrolyte Solution 
that can simultaneously contact said faradaic working elec 
trode and said capacitive counter electrode), plus a source of 
electrical energy capable of being electrically connectable to 
the faradaic working electrode and the capacitive counter 
electrode. Consistent with the principles of the invention, 
there are many possible sources of electrical energy. The 
electrical energy applied to the electrochemical cell can be 
generated using conventional instrumentation Such as poten 
tiostats, galvanostats, and/or similar instruments. In some 
embodiments, a Voltage source, a current source, a source of 
charge, and/or a power source can be used with either a 
constant or a time-varying waveform comprising offsets, 
steps, ramps, sinusoids, and combinations thereof. In some 
embodiments, a third electrode can be used as a feedback 
mechanism to control the Voltage across the faradaic working 
electrode. In some embodiments, the energy can come from a 
local energy store, Such as a battery, Super-capacitor, fly 
wheel, and/or a hydrocarbon Source (e.g., gasoline and/or 
methane). In some embodiments, a photovoltaic device can 
provide the energy. In some embodiments, power from the 
AC network can be used. In some embodiments, semicon 
ductor devices can use the energy store to control charge, 
Voltage, and/or current applied to the electrodes over time. In 
Some embodiments, a computing device (e.g., a microproces 
Sor, microcontroller, or computer) is used to control the appli 
cation of electrical energy to the electrochemical cell. 
In some embodiments, the apparatus comprises any of the 
above embodiments (for example, an apparatus comprising 1. 
an electrochemical cell comprising a faradaic working elec 
trode and a capacitive counter electrode wherein the electro 
chemical cell is capable of receiving an electrolyte Solution 
that can simultaneously contact said faradaic working elec 
trode and said capacitive counter electrode and 2. a source of 
electrical energy capable of being electrically connectable to 
the faradaic working electrode and the capacitive counter 
electrode), plus a magnet located so as to be able to exert a 
magnetic force on magnetizable particles located at the fara 
daic working electrode. 
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In some embodiments, the magnet can be reversibly moved 
from its position beneath the faradaic electrode to reduce the 
magnetic force applied on magnetizable beads in the sample 
by the magnet. 
In some embodiments, the magnet can comprise either a 
permanent magnet or an electromagnet. 
In some embodiments, the magnet can comprise a dipole 
magnet, a sandwich magnet, or a channel magnet. 
In some embodiments, the apparatus comprises any of the 
above embodiments (for example, an apparatus comprising 1. 
an electrochemical cell comprising a faradaic working elec 
trode and a capacitive counter electrode wherein the electro 
chemical cell is capable of receiving an electrolyte Solution 
that can simultaneously contact said faradaic working elec 
trode and said capacitive counter electrode and 2. a source of 
electrical energy capable of being electrically connectable to 
the faradaic working electrode and the capacitive counter 
electrode), plus a photodetector positioned to detect light 
emitted on the faradaic working electrode. In some embodi 
ments, the photodetector can be a photomultiplier tube, pho 
todiode, CMOS device, or a charge-coupled device. 
In some embodiments, the apparatus comprises any of the 
above embodiments (for example, an apparatus comprising 1. 
an electrochemical cell comprising a faradaic working elec 
trode and a capacitive counter electrode wherein the electro 
chemical cell is capable of receiving an electrolyte Solution 
that can simultaneously contact said faradaic working elec 
trode and said capacitive counter electrode and 2. a source of 
electrical energy capable of being electrically connectable to 
the faradaic working electrode and the capacitive counter 
electrode), plus a pump arranged to be able to move liquid 
across or onto the faradaic working electrode. In some 
embodiments, the pump can be modeled as a pressure source 
(e.g., an impeller pump, one that uses gravity, or a pump based 
on capillary action), or as a Volume Velocity source (e.g., a 
peristaltic pump, Syringe pump, gear pump, or positive dis 
placement pump). In some embodiments, the pump moves 
liquid across the faradaic working electrode. In some embodi 
ments, the pump is arranged to be able to move liquid across 
or onto the faradaic working electrode by using positive 
gauge pressures. In some embodiments, the pump is arranged 
to be able to move liquid across or onto the faradaic working 
electrode by using negative gauge pressures. In some embodi 
ments comprising a filter, the pump can be used to remove 
filtrate from the filter; for example, fluid can be moved 
through the filter by gravity flow or by pressure, in which 
positive gauge pressure is applied upstream of the filter or 
negative gauge pressure (vacuum) is applied downstream of 
the filter. This filtrate can, for example, be dispensed into the 
electrochemical cell and onto the faradaic working electrode. 
In some embodiments comprising a flow cell, the pump can 
be used to transport fluids into and out of the flow cell. 
The electrochemical cell can be used in conjunction with 
various automation systems such as an automatic drive 
mechanism or an alignment device to cause relative motion 
between the cell and the electrodes. An exemplary apparatus 
that comprises a flow-cell comprising a flow cell comprising 
capacitive counter electrode and a faradaic working electrode 
can further comprise a pump for aspirating and/or dispensing 
fluids into and out of the flow cell and an electrical energy 
source to drive the electrodes. In some embodiments, the 
exemplary apparatus can further comprise a fluid handling 
station for introducing one or more reagents and/or one or 
more samples that can include gases and liquids. The fluid 
handling station can comprise flow control valves as well as a 













ids from one or more locations into the cell. Additional flow 
control valves can also be present, as well as reagent/gas 
detectors. 
When a potential is applied to an electrochemical cell with 
a faradaic working electrode and a capacitive counter elec 
trode, electrons cross the faradaic electrode interface and a 
charge builds up in the capacitive electrode. The charge build 
up in the counter electrode can be described by the equation 
for a capacitor in an electrical circuit: q/V-C, where q is the 
charge on the capacitor (in coulombs), V is the potential 
across the capacitor (in Volts) and C is the capacitance (in 
Farads). The capacitance of an electrode may change as a 
function of the potential applied to the system; for example, 
the distance between the double layer and the electrode may 
increase as the amount of charge in the double layer increases. 
To a good approximation, the capacitive capability of an 
electrode is proportional to the Surface area exposed to the 
Solution. This electrochemical Surface area can be larger than 
the macroscopic geometrical Surface area by roughening the 
surface. The ratio of the electrochemical surface area to the 
macroscopic geometrical Surface area can be, for example, 
from about 1 to about 1000, or from about 1 to about 10, or 
from about 10 to about 100, or from about 100 to about 1000. 
The ratio of the electrochemical surface area to the macro 
scopic geometrical Surface area can be, for example, greater 
than or equal to about 1, about 2, about 3, about 5, about 10, 
about 30, about 100, about 300 or about 1,000. Methods to 
increase the roughness and thereby increase the electro 
chemical Surface area include mechanical abrasion (e.g., 
through the use of Sandpaper and/or sand blasting), plasma 
etching, ion and/or electron beam irradiation, depositing a 
rough coating (e.g., using techniques such as thermal spray, 
plating, or electrodeposition, ink-jet, Sputtering, chemical 
vapor deposition), chemical etching, laserablation, and elec 
trochemical surface modification. Other methods to obtain a 
large roughness include using a highly rough starting material 
as the electrode, for example, sintered particles, platinum 
black, carbon nanotubes and carbon black inks. To efficiently 
add to the electrochemical Surface area, the characteristic 
dimension of the roughness is preferably larger than (but not 
required to be) about 1 nm so that ions can easily contact all 
of the area. 
When employing a Voltage source to drive a capacitive 
counter electrode and a faradaic working electrode, the cur 
rent decreases with time as charge is trapped in the counter 
electrode (See FIG. 2). One might expect that the amount of 
current at the working electrode is limited by the amount of 
charge that can be contained in the counter electrode at the 
applied Voltage during operation of the electrochemical cell, 
which is determined by the capacitance of the electrode: 
however, this invention contemplates several methods of gen 
erating additional current, if additional current is desired. 
In some embodiments, the apparatus comprises any of the 
above embodiments, plus a mechanism to contact differing 
capacitive counter electrodes or differing areas of the same 
capacitive counter electrodes to an electrolyte solution that is 
contacting the faradaic working electrode. By exposing fresh 
parts of the counter electrode, the capacity increases thereby 
increasing the amount of current that can be driven through 
the working electrode. In some embodiments, the parts of the 
counter electrode that are charged can be unused for the 
remainder of the useful life of the cell. In some embodiments, 
the parts of the counter electrode that are charged can be 
discharged through contact with the air, through contact with 
another solution in a different cell, through the electrode's 
leakage current, or by reversing the direction of the current. 
By continuously exposing fresh parts of the counter elec 
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trode, faradaic currents at the working electrode can be mass 
transport limited by the reactants at the working electrode. 
FIG. 6 shows an exemplary embodiment of a cell whose 
counter electrode area exposed to the solution changes with 
time. The faradaic working electrode (201) can remain sta 
tionary in the cell while the capacitive counter electrode can 
be continuously moved through the electrolyte solution. For 
example, a conductive wire or film coated with a thin insu 
lating layer (202) can be passed through the electrolyte (204) 
under a fixed bias as shown in FIG. 6. Anions (203) can be 
removed from the solution when a negative bias is applied to 
the metal electrode and excess cations can be left in the 
solution to provide electroneutrality for the cathodic faradaic 
reaction. Similarly, cations can be removed at the capacitive 
counter electrode when the working electrode is an anode. 
Alternatively, a streaming mercury electrode with a Surface 
that is continuously renewed can be used if operated in the 
potential region where it behaves as an ideally polarized 
electrode. See, for details, I. M. Kolthoff, J. J. Lingane, 
Polarograghy, 2nd Ed, Vol. 1, Interscience Publishers, New 
York, p. 357, 1952. A Capacitive counter electrode can 
remove ions of a single polarity (i.e., without a counter ion) 
where the ionic charge can be compensated by electronic 
charge. 
Exemplary combinations of the apparatus components 
described above include an electrochemical cell comprising: 
a faradaic working electrode; a capacitive counter electrode: 
and a source of electrical energy. In certain embodiments, the 
present invention is directed to an apparatus comprising an 
electrochemical cell comprising: a cell capable of receiving 
an electrolyte solution, a faradaic working electrode; and a 
capacitive counter electrode. In some embodiments, the cell 
is a flow cell. 
Exemplary combinations of the apparatus components 
described above include an apparatus comprising an electro 
chemical cell used for performing a binding assay for an 
analyte in a sample based upon measurement of electro 
chemiluminescence at a faradaic working electrode surface, 
the electrochemical cell comprising: a cell for receiving a 
Solution comprising (a) sample comprising the analyte and 
(b) a labeled binding partner for the analyte wherein the 
labeled binding partner comprises an ECL moiety; a faradaic 
working electrode having an electrode Surface exposed to and 
positioned adjacent to a portion of the sample containing 
Volume; a capacitive counter electrode having the electrode 
Surface exposed to and positioned adjacent to a portion of the 
sample containing Volume; a source of electrical energy Suf 
ficient to generate luminescence; a magnet for collecting 
beads along the faradaic working electrode Surface; and a 
photodetector for measuring the amount of luminescence 
generated and, thereby, the quantity of analyte in the sample. 
Exemplary combinations of the apparatus components 
described above include an apparatus comprising an electro 
chemical cell for use in analyzing a sample Suspected of 
containing one or more analytes comprising: a filter fluidi 
cally connected to a sampling device; a pump arranged to be 
able to drive liquid flow across the filter; a cell for receiving a 
filtered sample Suspected of containing one or more analytes; 
at least one faradaic working electrode; and at least one 
capacitive counter electrode; and means for measuring the 
quantity of analyte in the sample. 
IV. EXEMPLARY METHODS 
The invention also contemplates methods of use, for 
example, of apparatus embodiments described above. These 













presence or amount of one or more analytes in a sample and 
methods of generating at least one electrochemical product at 
a working electrode while generating a discordantly smaller 
amount of electrochemical byproduct at a counter electrode. 
In some embodiments, the method for determining the 
presence or amount of an analyte in a sample comprises the 
steps of contacting both a faradaic working electrode and a 
capacitive counter electrode with a solution comprising the 
sample and an electrolyte; Supplying electrical energy 
between the faradaic working electrode and the capacitive 
counter electrode sufficient to provide for faradaic charge 
transfer at the faradaic working electrode; measuring at least 
one of (i) light, (ii) current, (iii) Voltage, and (iv) charge to 
determine the presence or amount of the analyte in the 
sample. 
In some embodiments, the method for determining the 
presence or amount of an analyte in a sample comprises the 
steps of 
(a) optionally preprocessing the sample: 
(b) contacting a faradaic working electrode to a solution 
comprising the optionally pre-processed sample; and an elec 
trolyte; 
(c) contacting a capacitive counter electrode to the solu 
tion; 
(d) supplying electrical energy between the faradaic work 
ing electrode and the capacitive counter electrode sufficient to 
provide for faradaic charge transfer at the faradaic working 
electrode: 
(e) measuring at least one of (i) light, (ii) current, (iii) 
Voltage, and (iv) charge to determine the presence or amount 
of the analyte in the sample. 
Exemplary methods utilizing the measurement of light 
include luminescence assays, including fluorescence, chemi 
luminescence, and electrochemiluminescence assays. Exem 
plary methods utilizing the measurement of current include 
measuring the rate of generation of an electrochemical reac 
tive species in the solution that is consumed by the faradaic 
working electrode. Exemplary methods utilizing the mea 
Surement of Voltage include ion-selective electrodes. Exem 
plary methods utilizing the measurement of charge include 
measuring the capacitance of the capacitive counter electrode 
from which, for example, the concentration of the dominate 
ion and/or the Debye length of the solution can be estimated. 
Exemplary methods utilizing a combination of measurements 
include cyclic Voltammograms involving measuring both cur 
rent and Voltage to examine, e.g., oxidization and reduction 
behavior in the solution. Various properties or combinations 
of properties of the physical measurements of light, current, 
Voltage, and/or charge can be used to determine the quantity 
of analyte in the sample; for example, wavelength, frequency, 
energy, intensity, polarity, polarization, amplitude, waveform 
shape, and/or time dependency can be used. 
In some embodiments, the solution used in the determina 
tion of the presence or amount of an analyte in a sample 
further comprises an ECL moiety, for example, those ECL 
moieties that comprise ruthenium or osmium. In some 
embodiments, the solution further comprises an ECL coreac 
tant, for example, tertiary amines with and without hydro 
philic functional groups, tertiary amines with alkyl groups 
optionally comprising hydrophilic functional groups, bio 
logical buffers with tertiary amines, and/or oxalate. In some 
embodiments, the electrical energy Supplied between the 
faradaic working electrode and the capacitive counter elec 
trode is sufficient to induce electrochemiluminesce and the 
quantity of analyte in the sample is determined by measuring 
luminescence. In some embodiments, the Solution further 
comprises at least one of a labeled binding partner for an 
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analyte and a labeled analog of the analyte. In some embodi 
ments, the solution further comprises a second binding part 
ner for the analyte wherein the second binding partner is 
linked to a Support. In some embodiments, the Support is a 
magnetizable bead. 
In some embodiments, the method for determining the 
presence or amount of an analyte in a sample comprises the 
step of pre-processing the sample. Pre-processing can be, for 
example, filtering the sample through a filter to form a filtrate. 
Exemplary pore size ratings of the filter include those falling 
in the ranges of about 10 um to about 100 um, about 1 um to 
about 10 Lim, about 0.1 um to about 1 lum, and about 0.02 um 
to about 0.1 um. Other pre-processing steps can be, for 
example, mixing the sample with a reagent whose pH is 
greater than 8 or less than 6 and an osmolarity is greater than 
or equal to 0.1 osmol/L. Other pre-processing steps can be, 
for example, mixing the sample with a reagent whose osmo 
larity is greater than or equal to 1.1 osmol/L. 
In some embodiments, the assay methods can comprise the 
steps of inducing an ECL moiety in Solution to emit light by 
applying an electrochemiluminescence-inducing electrical 
waveform to the working electrode in the presence of the ECL 
moiety; and measuring the luminescence emitted by the ECL 
moiety. In some embodiments, the assay methods can com 
prise the step of adding a second binding partner linked to a 
Support (e.g., a magnetizable bead). In some embodiments 
using magnetizable beads, the method can comprise the steps 
of magnetically collecting the magnetizable beads along the 
faradaic working electrode Surface through the use of a mag 
net (e.g., a permanent magnet or an electromagnet) that can 
optionally be reversibly removed from its location beneath 
the faradaic working electrode. 
In some embodiments, the assay methods can employ a 
faradaic current flow through the faradaic working electrode 
that alternates in direction to reduce the potential across the 
capacitive counter electrode. 
The present invention can be used for coulometric pro 
cesses, for example, in micro and nanoscale electrochemical 
cells. In some embodiments, the present invention can be 
used to reduce the generation of an undesirable or destructive 
product at the counter electrode in an electrochemical cell. In 
Some embodiments, the present invention can be used in 
electrochemiluminescent assays where the amount of an ana 
lyte in a sample can be determined by the amount of light 
generated at the working electrode, for example, in nanos 
caled ECL assays where electrochemical products generated 
at the counter electrode have sufficient time to diffuse near the 
working electrode and may interfere with the assay. 
The samples that can be analyzed using an electrochemical 
cell of the present invention can comprise at least one analyte. 
Measurementofananalyte in the sample can be carried out by 
any of the numerous techniques available in the art of bio 
logical assays, including but not limited to, nucleic acid 
hybridization assays, nucleic acid amplification assays, cell 
culture-based assays, agglutination tests, immunoassays (or 
other assay formats based on the use of specific binding 
partners of the marker of interest), immunochromatographic 
assays, enzymatic assays, etc. The detection method can be a 
binding assay, Such as an immunoassay, and the detection can 
be performed by contacting an assay composition with one or 
more binding partners of the analyte. In certain embodiments, 
the assay uses a sandwich or competitive binding assay for 
mat. Examples of sandwich immunoassays performed on test 
strips are described by U.S. Pat. No. 4,168,146 to Grubb et al. 
and U.S. Pat. No. 4.366,241 to Tom et al. Examples of com 
petitive immunoassay devices suitable for use with the 













4,235,601 to Deutsch et al., U.S. Pat. No. 4,442,204 to Liotta, 
and U.S. Pat. No. 5,208,535 to Buechler et al. In certain 
embodiments, at least one of the binding partners employed 
in Such an assay is immobilized on a Support. In some 
embodiments, a labeled binding partner and/or a labeled ana 
log of the analyte is used in the binding reactions. In some 
embodiments, the labeled binding partner comprises an ECL 
moiety. 
A binding partner can be immobilized on the Support by 
any conventional means, e.g., adsorption, absorption, nonco 
Valent binding, covalent binding with a crosslinking agent, or 
covalent linkage resulting from chemical activation of either 
or both of the support or the binding partner. In some embodi 
ments, the immobilization of the binding partner by the Sup 
port can be accomplished using a binding pair. For example, 
one member of the binding pair, e.g., Streptavidin or avidin, 
can be bound to the support and the other member of the same 
binding pair, e.g., biotin, can be bound to the first binding 
partner. Suitable means for immobilizing a binding partner on 
the Support are disclosed, for example, in the Pierce Catalog, 
Pierce Chemical Company, P.O. Box 117, Rockford, Ill. 
61105, 1994. 
A. Certain Assay Methods 
Binding assays can be carried out using magnetizable 
beads as a Support for a solid phase binding assay using a flow 
cell-based design with permanent reusable flow cells, or 
single use replaceable cells. Complexes comprising an ECL 
moiety that are bound to magnetizable beads can be collected 
on an electrode in the flow cell with the aid of a magnet, for 
example, a dipole magnet, a sandwich magnet, a channel 
magnet and/or an electromagnet. The labels on the collected 
beads can be induced to emit ECL by application of a poten 
tial to the electrodes and the ECL can be measured to measure 
the amount of label. The ECL assay method can also comprise 
the step of introducing an ECL coreactant prior to application 
of the ECL-inducing potential. 
In certain embodiments, a Solid phase sandwich immu 
noassay can be run using the electrochemical cell of this 
invention. Two antibodies directed against the analyte are 
used: i) a capture antibody that is linked or capable of being 
linked (e.g., through the formation of a specific binding pair 
Such as a biotin-streptavidin interaction) to a solid phase and 
ii) a detection antibody that is linked or capable of being 
linked (e.g., through the formation of a specific binding pair 
Such as a biotin-streptavidin interaction) to a label, for 
example an ECL moiety. A sample comprising the Solubilized 
analyte can be contacted with the two antibodies and the solid 
phase so that in the presence of the analyte the two antibodies 
can bind to the analyte to form a “sandwich complex' on the 
solid phase comprising the label. The label on the solid phase 
can be measured so as to measure the analyte in the sample. 
The sample can be introduced into the cell as-collected or 
the sample can undergo one or more preparations steps. See 
for example, THE IMMUNOASSAY HANDBOOK, 
3.sup.rd edition, David Wild editor, Elsevier, 2005. 
In certain embodiments, the present invention can provide 
a method of detecting an analyte in a sample comprising the 
steps of providing a cell for receiving an electrolyte Solution 
and the sample which may comprise the analyte; placing the 
electrolyte Solution in the cell; placing the sample in the cell; 
contacting a faradaic working electrode with the sample and 
electrolyte solution; contacting a capacitive counter electrode 
with the sample and electrolyte Solution; Supplying electrical 
energy to the electrodes sufficient to provide for faradaic 
charge transfer at the faradaic working electrode that can 
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generate an electrochemical product; and determining the 
quantity of analyte in the sample. 
In certain embodiments, the present invention can provide 
a method for determining the presence or amount of an ana 
lyte in a sample comprising the steps of (1) forming a solution 5 
comprising (a) the sample, (b) a labeled binding partner spe 
cific for said analyte wherein the label is an ECL moiety, (c) 
a binding partner specific for said analyte linked to a magne 
tizable bead, (d) an ECL coreactant, and (e) an electrolyte; (2) 
contacting a faradaic working electrode and a capacitive 
counter electrode with the solution; (3) collecting the beads 
along the faradaic working electrode; (4) Supplying electrical 
energy to the electrodes to cause the ECL moiety to repeat 
edly generate electrochemiluminescence; (5) measuring said 
electrochemiluminescence; and (6) determining presence or 
amount of said analyte from the measurement. 
In some embodiments, the method can be a method for 
analyzing the sample for multiple analytes. For example, an 
array of faradaic working electrodes can be used with one or 20 
more capacitive counter electrodes wherein a measurement 
from one or more faradaic working electrodes is used to 
measure each analyte. For example, one or more faradaic 
working electrodes can be used with one or more capacitive 
counter electrodes wherein more than one analyte is mea- 25 
Sured on each faradaic working electrode. 
In some embodiments, the method of generating at least 
one electrochemical product at a working electrode while 
generating a discordantly Smaller amount of electrochemical 
byproduct at a counter electrode, comprises contacting a fara 
daic working electrode and a capacitive counter electrode 
with an electrolyte solution; and applying electrical energy 
between the faradaic working electrode and the capacitive 
counter electrode wherein the faradaic charge transferred 
across the faradaic working electrode is greater than the fara 
daic charge transferred across the capacitive counter elec 
trode. 
The discord in the amount of byproduct formed, relative to 
the amount of product formed, is primarily a result of the 40 
discord in faradaic charge transfer at the working and counter 
electrodes. In an apparatus of the present invention, and 
unlike traditional electrochemical apparatus, the amount of 
charge transferred at the faradaic working electrode is greater 
than the amount of charge that is transferred at the capacitive 45 
counter electrode. The difference in the amount of charge 
transferred at the working and counter electrodes can be, for 
example, greater than or equal to a factor of about 5; about 10; 
about 30; about 100; about 300; about 1,000; about 3,000; 
about 10,000, about 100,000; or more. In some embodiments 50 
the discord in faradaic charge transfer can be in the range of 
from about 5 to about 100,000, or from about 5 to about 
10,000, or from about 5 to about 1,000, or from about 5 to 
about 100, or from about 10 to about 100,000, or from about 
10 to about 10,000, or from about 10 to about 1,000, or from 55 
about 10 to about 100, or from about 30 to about 100,000, or 
from about 30 to about 10,000, or from about 30 to about 
1,000, or from about 30 to about 300, or from about 100 to 
about 100,000, or from about 100 to about 10,000, or from 
about 100 to about 1,000. 60 
In electrochemical cells known in the art, there may be a 
difference in the amount of byproduct formed at the counter 
electrode, relative to the amount of product formed at the 
working electrode when the half-cell reactions that occur at 
each of these electrodes requires a differing number of elec- 65 
trons. The difference between the amount of electrochemical 






chemical byproduct at the capacitive counter electrode is 
determined by the stoichiometry of the redox reactions 
involved. 
Taking into consideration the discord in faradaic charge 
transfer, the possibility that a different number of electrons 
can be required for each of the half-cell reactions, and any 
other processes that affect the amount of byproduct that is 
formed, a discordantly Smaller amount of byproduct is 
formed at the counter electrode if the ratio of product to 
byproduct is greater than or equal to a factor of about 2; about 
5; about 10; about 30; about 100; about 300; about 1,000; 
about 3,000; about 10,000, about 100,000; about 200,000 or 
more. For example, if the ratio of the amount of faradaic 
charge transferred across the working and counter electrodes 
is 30 and all the electrochemical reactions at the counter 
electrode require 1 electron while all the electrochemical 
reactions at the working electrode require 2 electrons, then 
the ratio of product to byproduct would be 15. In some 
embodiments, the ratio of product to byproduct can be in the 
range of from about 2 to about 200,000, or from about 2 to 
about 20,000, or from about 2 to about 2,000, or from about 2 
to about 200, or from about 5 to about 200,000, or from about 
5 to about 20,000, or from about 5 to about 2,000, or from 
about 5 to about 200, or from about 15 to about 200,000, or 
from about 15 to about 20,000, or from about 15 to about 
2,000, or from about 15 to about 600, or from about 50 to 
about 200,000, or from about 50 to about 20,000, or from 
about 50 to about 2,000. 
Coulometric methods can be used to add a small measur 
able amount of a species into a system, for example, into a 
nanosystem using an ultramicroelectrode (UME). Because of 
the Small size of nanosystems, the usual cell separators cannot 
easily be employed to prevent the undesired products gener 
ated at the counter electrode from being introduced into the 
system. Utilizing a system with a faradaic working electrode 
and a capacitive counter electrode can allow both electrodes 
to be in contact with the electrolyte solution in a single cell, 
while reducing or preventing the production of undesired 
products. 
When the polarity of the electrical energy applied to the 
electrodes is changed with time, current can flow alternately 
in both directions. For example, when the capacitive counter 
electrode charges to a large Voltage, the polarity of the elec 
trical energy can be reversed to discharge the capacitive 
counter electrode. Optionally, the counter electrode can be 
charged with the opposite polarity. During this Switching 
process, the faradaic working electrode can act in turn as an 
anode and as a cathode (depending on the direction of current 
flow). While the use of two faradaic electrodes can cause both 
anodic and cathodic reactions to occur at the same time at 
differing places, this invention enables the anodic and 
cathodic reactions to occur at differing times at the same 
place. This temporal separation can be useful in several cir 
Cumstances. 
B. Temporal Separation Methods 
Temporal separation can be useful where the counter and 
working electrodes are Sufficiently close that reaction prod 
ucts from one electrode could, if generated at the same time, 
diffuse to and interfere with the reaction at the other electrode. 
For example, in-situ generation of chlorine gas from chloride 
ions in aqueous solution can be compromised by generation 
of hydroxy ions at a faradaic counter electrode by the forma 
tion of hypochlorite. Through time separation, the desired 
product (e.g., chlorine gas) can be used or removed (e.g., via 
US 8,840,774 B2 
33 
diffusion or convection) from the electrodes before the com 
promising reaction occurs. The removal can be considered as 
a temporal-spatial separation. 
In some embodiments, the temporal-spatial separation can 
be created by flowing liquids past the electrodes. The liquid 
downstream of the electrode can then comprise alternating 
cathodic and anodic reaction products. For example, a solu 
tion comprising dissolved oxygen gas and chloride ions can 
generate alternately chlorine gas and hydrogen peroxide 
downstream of the electrodes. This combination can be used, 
for example, for decontaminating a device or cartridge. In 
Some embodiments, temporal-spatial separations can be cre 
ated by reaction products differing in density (e.g., a gas and 
an ion). By giving the gas product time to diffuse away from 
the working electrode before the ion is created, the reaction 
products can be separated. 
In some embodiments, the temporally separated reaction 
products are not spatially separated; rather they can be alter 
nately used in situ. For example, the pH of a reaction cell can 
be alternately adjusted up and down by 1, 2, 3, 4, or more pH 
units by the faradaic creation of hydroxy or hydronium ions. 
Cycling the chemical environment in a region can have sev 
eral uses. For example, a new method of DNA amplification 
can be made creating strand separation and renaturation 
cycles not by cycling temperature as is done in PCR, but by 
cycling the chemical environment. 
C. Additional Embodiments of Apparatus and Assays 
Useful for Certain Methods 
In some embodiments, the present invention is directed to 
an apparatus comprising an electrochemical cell comprising: 
a faradaic working electrode; a capacitive counter electrode: 
and a container capable of receiving an electrolyte solution. 
In some embodiments, the electrochemical cell at least 
partially encloses a sample Volume. 
In some embodiments, the electrochemical cell further 
comprises a reference electrode. 
In some embodiments, the apparatus further comprises an 
assay-performance-substance comprising a labeled binding 
partner for an analyte or a labeled analog of the analyte. 
In some embodiments, the apparatus further comprises a 
filter in fluidic connection to the faradaic working electrode 
and the capacitive counter electrode. 
In some embodiments, the apparatus further comprises a 
Source of electrical energy capable of being electrically con 
nectable to the faradaic working electrode and the capacitive 
counter electrode. 
In some embodiments, the apparatus further comprises a 
photodetector positioned to detect light emitted on, at or near 
the faradaic working electrode. 
In some embodiments, the apparatus further comprises a 
pump arranged to be able to move liquid across or onto the 
faradaic working electrode. 
In some embodiments, the present invention is directed to 
a method of for determining the presence or amount of an 
analyte in a sample comprising the steps of 
(a) optionally preprocessing the sample: 
(b) contacting a faradaic working electrode to a solution 
comprising the optionally pre-processed sample; and an elec 
trolyte; 
(c) contacting a capacitive counter electrode to the Solu 
tion; 
(d) Supplying electrical energy between the faradaic work 
ing electrode and the capacitive counter electrode sufficient to 














(e) measuring at least one of (i) light, (ii) current, (iii) 
Voltage, and (iv) charge to determine the presence or amount 
of the analyte in the sample. 
In some embodiments, the sample is not pre-processed. 
In some embodiments, the sample is pre-processed by 
filtering the sample with a filter, wherein the filter has a pore 
size rating less than or equal to about 100 microns and greater 
than or equal to about 10 microns 
In some embodiments, the sample is pre-processed by 
filtering the sample with a filter, wherein the filter has a pore 
size rating less than or equal to about 10 microns and greater 
than or equal to about 1 microns. 
In some embodiments, the sample is pre-processed by 
filtering the sample with a filter, wherein the filter has a pore 
size rating less than or equal to about 1 micron and greater 
than or equal to about 0.1 microns. 
In some embodiments, the sample is preprocessed by fil 
tering the sample with a filter, wherein the filter has a pore size 
rating less than or equal to about 0.1 micron and greater than 
or equal to about 0.02 microns. 
In some embodiments, the Solution further comprises an 
assay-performance-substance comprising a labeled binding 
partner for an analyte or a labeled analog of the analyte. 
In some embodiments, the label of the labeled binding 
partner for the analyte and/or the labeled analog of the analyte 
is the ECL moiety. 
In some embodiments, the amount of analyte in the sample 
is determined by activating the ECL moiety in solution by 
applying an electrochemiluminescence-inducing electrical 
waveform to the faradaic working electrode; and measuring 
the luminescence emitted by the ECL moiety. 
In some embodiments, the Solution further comprises a 
second binding partner for the analyte wherein the second 
binding partner is linked to a Support. In some embodiments, 
the Support is a magnetizable bead. 
In some embodiments, the method is a method for analyZ 
ing the sample for multiple analytes. 
In Some embodiments, the reagent that aids in the detection 
of the analyte or the first binding partner is an electrolyte. 
In some embodiments, the first binding partner is a labeled 
binding partner. 
In some embodiments, the labeled binding partner com 
prises an ECL moiety. 
In Some embodiments, the reagent that aids in the detection 
of the analyte or the first binding partner is an ECL coreactant. 
In some embodiments, the first binding partneris measured 
by measuring the electrochemiluminescence emitted by the 
ECL moiety by: 
(a) inducing the ECL moiety in solution to emit light by 
applying an electrochemiluminescence-inducing electrical 
waveform to the working electrode in the presence of the ECL 
moiety; and 
(b) measuring the luminescence emitted by the ECL moi 
ety. 
In some embodiments, the method further comprises the 
step of adding to filtrate of step (b) a second binding partner 
for the analyte wherein the second binding partner is linked to 
a Support. In some embodiments, the Support is a magnetiz 
able bead. 
In some embodiments, the method further comprises the 
step of magnetically collecting the magnetizable beads along 
the faradaic working electrode Surface through the use of a 
magnet. 
In some embodiments, the faradaic current flow at the 
faradaic working electrode alternates in direction to reduce 
the potential across the capacitive counter electrode. 
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In some embodiments, the present invention is directed to 
a method of generating at least one electrochemical product at 
a working electrode while generating a discordantly smaller 
amount of electrochemical byproduct at a counter electrode, 
comprising: 
contacting a faradaic working electrode with an electrolyte 
Solution; 
contacting a capacitive counter electrode with the electro 
lyte Solution; and 
applying electrical energy between the faradaic working 
electrode and the capacitive counter electrode 
wherein the faradaic charge transferred across the faradaic 
working electrode is at least about 10 times the faradaic 
charge transferred across the capacitive counter electrode. 
In some embodiments, the faradaic charge transferred 
across the faradaic working electrode is at least about 100 
times the faradaic charge transferred across the capacitive 
counter electrode. 
In some embodiments, the faradaic charge transferred 
across the faradaic working electrode is at least about 1,000 
times the faradaic charge transferred across the capacitive 
counter electrode. 
In some embodiments, the applied electrical energy alter 
nates in the polarity to form at least one oxidative product and 
at least one reductive product at the working electrode. 
In some embodiments, the faradaic working and capacitive 
counter electrodes are located in a flow cell and movement of 
the oxidative and reductive products away from the faradaic 
working electrode surface is facilitated by a flow of the elec 
trolyte solution through the flow cell. 
In some embodiments, the rate of alternating the polarity of 
the electrical energy applied to the electrodes is sufficient to 
allow either the oxidative product to move away from the 
electrode before the reductive product is formed or to allow 
the reductive product to move away from the electrode before 
the oxidative product is formed. 
In some embodiments, the electrolyte solution comprises 
dissolved oxygen gas and chloride ions. 
In some embodiments, the product of one of the oxidative 
half-cell reactions or the reductive half-cell reactions is a gas 
and the other product is an ion. 
In some embodiments, the oxidative product comprises 
chlorine gas and the reductive product comprises hydrogen 
peroxide. 
In some embodiments, the oxidative product and the reduc 
tive product are used as part of a decontamination process. 
In some embodiments, the oxidative product and the reduc 
tive product is a gas and the other is an ion. 
In some embodiments, the amount of the electrochemical 
product is increased by exposing an area of the counter elec 
trode to the electrolyte solution that was previously unex 
posed to the electrolyte solution. 
EXAMPLES 
The following examples serve to more fully describe the 
manner of using the above-described invention. It is under 
stood that these examples in no way serve to limit the true 
scope of this invention, but rather are presented for illustrative 
purposes. The following abbreviations have the following 
meanings. If an abbreviation is not defined within the appli 
cation, the abbreviation has its generally accepted meaning 

































Measurement of Faradaic Current at a Working 
Electrode in an Electrochemical Cell Having a 
Capacitive Counter Electrode 
A 25 um diameter Pt wire (101) sealed in a glass UME 
(102) tip served as the faradaic electrode and contacted a few 
mm diameter drop of deionized (MilliO) water placed on the 
SiO, film (500 nm thick) on a single crystal Si wafer (100) 
with a thin insulating film of SiO functioning as the capaci 
tive electrode. Samples of SiO/Si were prepared at SEMAT 
ECH (Austin, Tex.) by chemical vapor deposition without 
further treatment. In experiments where a water drop was 
moved along the SiO, Surface under a bias as shown sche 
matically in FIG. 1, a 2 mm diameter glass tube (103) was 
attached to the 25 um Pt tip with parafilm to avoid water 
leakage. The tube was slightly over filled so that a water drop 
(104) was formed at its top to contact the SiO surface and the 
drop could be moved horizontally to continuously make con 
tact with a fresh part of the oxide surface. The total faradaic 
charge injected at the Pt electrode is given by Q, ?idt 
Qe, fidt-CarAAE-CatsAs AE-CiteAp,AE (1) where 
Q, is the total faradaic charge injected, i, the total current, 
Q.e., the capacitive charge at the Pt electrode, Cale, the 
integral capacitance of the Pt electrode, Cats, the integral 
capacitance of the Sielectrode, A, and As, the areas of Ptand 
Sielectrodes, respectively, and AE, the applied bias. 
Once the current became negligibly small, the external 
circuit was disconnected for about 8 s. When it was recon 
nected at the same bias, the charging current was significantly 
smaller as shown in FIG. 2, (inset) in which the initial sharp 
spike was an electronic artifact resulting from capacitive cou 
pling. When the circuit was opened for a longer time, Such as 
15 to 20 S, the charging current after reconnection did not 
appear very different than that in the inset in FIG. 2. This 
demonstrates that the electronic and ionic charges brought to 
the SiO, interface by the external potential changed only 
slightly at open circuit. 
Example 2 
Measurement of Faradaic Current at a Moving 
Working Electrode in an Electrochemical Cell 
Having a Capacitive Counter Electrode 
Using the set up described in Example 1, the water drop 
(104) and associated Pt UME (101) were moved across the 
SiO surface under a constant bias. Before movement, a bias 
of-1 V was applied to the tip and the surface became fully 
charged. Then, the tip was moved laterally by pushing the 
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translation stage (105) manually at a rate of roughly 1 cm/s 
over a distance of about 0.5 to 4 cm without disconnecting the 
bias and the current increased as shown in FIG.3. The current 
reached a steady state at the nA level, which was maintained 
by continuous exposure to fresh surface. The current did not 
drop until the movement ended and the charging at this loca 
tion approached saturation (FIG. 3). The contact area of the 
SiO electrode and the water drop remained essentially con 
stant during the lateral tip movement. The steady state current 
depended on how fast the fresh surface was contacted. At a tip 
movement rate of 25 um/s, controlled with an inchworm 
motor, the steady state current was about 3 p.A (the leakage 
current was not detectable (noise floor-1 p.A) with such a 
thick oxide layer). The 25 um movement of the water drop in 
1 s generated a new contact area corresponding to a capaci 
tance of -5 pF assuming a parallel capacitor with SiO, as the 
dielectric material. In other words, under a bias of 1 V 
neglecting potential drops at the Ptelectrode and the Solution 
resistance, a maximum current of ~5 pA should be obtained 
compared to the actual current of 3 p.A actually observed. At 
Such a low rate of tip displacement, it took several minutes for 
the water drop to completely move away from its previous 
spot. Probably the stored charge on both interfaces of SiO, 
(ions in Solution and electronic charge in the Si) either did not 
move or moved too slowly to follow the water drop. The 
observed behavior did not depend on the polarity of the bias 
applied to the system. When a Supporting electrolyte Such as 
0.1M NaSO was introduced, the system charged more 
quickly because of the decrease of solution resistance. How 
ever the basic features were the same. 
The results shown in FIG. 3 could be reproduced many 
times at different locations. Similar results were also obtained 
as the tip traveled in a stepwise, repeated stop-and-go mode as 
shown in FIG. 4. Each time, the charging current increased as 
the water drop started to move, and a steady state charging 
current was seen and decreased when the water drop stopped 
moving. 
The capacitive electrode's surface of SiO, was hydropho 
bic (contact angle with pure water about 87° C.) and no 
visible trace of water was left after the drop moved away from 
a spot. In some cases, the water drop was moved in a pre 
designed pattern so that the location of each stop could be 
revisited later. When the water drop was moved back to those 
spots, which had been previously fully charged, after a period 
of 10 to 20 min, no appreciable charge could be observed 
under the same charging conditions (the charging current was 
comparable to the one shown in the inset of FIG. 1), confirm 
ing that the charges remained at their original spot and did not 
move anywhere else. Moreover, stored charges were not dis 
charged at a neighboring spot that was about 7.5 mm away, 
indicating that there was no communication among stored 
charges at different locations. Independent of the charging 
history, all of the spots could be restored to their initial state 
by discharging the Si under short circuit conditions. These 
findings agree with earlier studies of the emersion of a metal 
electrode from Solution into high vacuum, which indicated 
that the solution-formed double layer still existed in the high 
vacuum chamber after charging of the metal electrode in 
Solution and then transfer to vacuum under a bias. See 
Hansen, et al., J. Electroanal. Chem., 1978, 93, 87 for further 
details. 
A typical steady charging current was seen when the tip 
was stationary and the potential was scanned at a rate of 100 
mV/s as shown in the inset of FIG. 3. The calculated capaci 
tance (Ci/V, where i and V are current and scan rate, respec 
tively) of 0.577 nF corresponding to 6.9 nF/cm from this 














as the dielectric material (C=66A/d, where 6 is the relative 
permittivity of the dielectric material, 3.9 for SiO; e, the 
permittivity of space: A the area, and d is 500 nm, the thick 
ness of SiO) with a diameter of 3.2 mm, which closely 
matched the actual area contacted by the drop. 
Example 3 
Measurement of ECL at in an Electrochemical Cell 
Having a Capacitive Counter Electrode 
A 250 um Pt wire was bent at a right angle, coated with 
epoxy cement and then polished to expose an area of about 
0.02 mm facing a photomultiplier tube (PMT, R4220p, 
Hamamatsu, Bridgewater, N.J.). A piece of Si with an area of 
~40 cm and coated with a ~50 nm thick SiO, film was used 
the counter electrode in an aqueous solution containing 0.5 
mM Ru(bpy), "tris(2,2'-bipyridine)ruthenium(II) in 0.10 
M tri-n-propylamine (TPA) with 0.10 M Tris/0.10 M LiClO. 
buffer (pH=8). An Autolab potentiostat (Model PGSTAT100, 
EcoChemie, Utrecht, The Netherlands) was used to control 
the applied potential with Pt as the working electrode and the 
Siback contact as the counter electrode. The reference elec 
trode input on the potentiostat was connected to the counter 
electrode. The ECL emission and the current were recorded 
simultaneously during the measurement. Potential pulses 
from 1.4V (30s) to -0.5 V (20s) were applied to the system 
Pt/solution/SiO/Si. In a separate measurement to obtain an 
ECL image, a 25 um Pt UME tip was used with the same 
solution over a 9 cm Si/SiO, surface mounted on the stage of 
an inverted microscope (Nikon, Model TE300, Melville, 
N.Y.). For additional experimental options see also Bard, A. 
J. Ed., Electrogenerated Chemiluminescence, Marcel Dek 
ker, New York, 2004 and Miao, et al., J. Am. Chem. Soc., 
2002, 124, 14478 and references therein. 
ECL was generated by potential steps applied between a 
0.02 mm.sup.2 Ptelectrode and a Si/SiO, (40 cm) electrode. 
As shown in FIG. 5, ECL was detected immediately follow 
ing the application of a potential pulse of 1.4 V to the Pt 
electrode, triggering a negative charging process at the SiO, 
interface. As the charging current decreased, the ECL emis 
sion intensity decreased. The decreasing current in this case 
represents charging of the counter electrode rather than the 
usual reactant depletion at the Pt electrode. As expected, no 
ECL was seen under a negative bias of -0.5V, which served, 
however, to discharge the interface at the Si/SiO, electrode 
(with a corresponding faradaic reaction at the Pt electrode). 
This cycle could be repeated many times and the ECL inten 
sity decreased slightly each time probably due to the deple 
tion of active species near the Pt electrode surface. ECL was 
not detected at the blocked electrode whose leakage current 
was therefore negligible. In a different measurement with a 25 
um Pt tip over a 9 cm Si/SiO, electrode with the same 
Ru(bpy), "7TPA solution under a constant bias of 1.4 V, an 
ECL image of the Pt tip was clearly seen with an inverted 
microscope as shown in the inset in FIG. 5. The production of 
ECL provides clear evidence for a faradaic process in the 
single electrode electrochemical system and shows that ECL 
can be generated in a microcell without interference from 
counter electrode reactions. 
All references cited herein are incorporated by reference in 
their entirety. To the extent publications and patents or patent 
applications incorporated by reference contradict the disclo 
Sure contained in the specification, the specification is 
intended to Supersede and/or take precedence over any Such 
contradictory material. 
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All numbers expressing quantities of ingredients, reaction 
conditions, and so forth used in the specification and claims 
are to be understood as being modified in all instances by the 
term “about. Accordingly, unless indicated to the contrary, 
the numerical parameters set forth in the specification and 5 
attached claims are approximations that can vary depending 
upon the desired properties sought to be obtained by the 
present invention. At the very least, and not as an attempt to 
limit the application of the doctrine of equivalents to the scope 
of the claims, each numerical parameter should be construed 
in light of the number of significant digits and ordinary round 
ing approaches. 
10 
The foregoing description of possible implementations 
consistent with the present invention does not represent a 
comprehensive list of all such implementations or all varia- 15 
tions of the implementations described. The description of 
only some implementation should not be construed as an 
intention to exclude other implementations. Artisans will 
understand how to implement the invention in the appended 
claims in many other ways, using equivalents and alternatives 
that do not depart from the scope of the following claims. 
Moreover, unless indicated to the contrary in the preceding 
description, none of the components described in the imple 
mentations is essential to the invention. 
What is claimed is: 
1. A method of generating at least one electrochemical 
25 
product at a working electrode while generating a discor 
dantly Smaller amount of electrochemical byproduct at a 
counter electrode, comprising the steps of: 
contacting a faradaic working electrode with an electrolyte 
Solution; 
contacting a capacitive counter electrode with the electro 
lyte solution; and 
applying electrical energy between the faradaic working 
electrode and the capacitive counter electrode; 
wherein applying the electrical energy effects a faradaic 
charge transfer across the faradaic working electrode 
that is at least about 10 times an amount of faradaic 
charge transferred across the capacitive counter elec 
trode, thus generating a discordantly smaller amount of 40 




2. The method of claim 1, wherein the faradaic charge 
transferred across the faradaic working electrode is at least 
about 100 times the faradaic charge transferred across the 
capacitive counter electrode. 
3. The method of claim 1, wherein the faradaic charge 
transferred across the faradaic working electrode is at least 
about 1,000 times the faradaic charge transferred across the 
capacitive counter electrode. 
4. The method of claim 1, wherein the applied electrical 
energy alternates in the polarity to form at least one oxidative 
product and at least one reductive product at the working 
electrode. 
5. The method of claim 1, wherein the faradaic working 
and capacitive counter electrodes are located in a flow cell and 
movement of the oxidative and reductive products away from 
the faradaic working electrode surface is facilitated by a flow 
of the electrolyte solution through the flow cell. 
6. The method of claim 4, wherein a rate of alternating the 
polarity of the electrical energy applied to the electrodes is 
sufficient to allow either the oxidative product to move away 
from the electrode before the reductive product is formed or 
to allow the reductive product to move away from the elec 
trode before the oxidative product is formed. 
7. The method of claim 1, wherein the electrolyte solution 
comprises dissolved oxygen gas and chloride ions. 
8. The method of claim 7, wherein the oxidative product 
comprises chlorine gas and the reductive product comprises 
hydrogen peroxide. 
9. The method of claim 1, wherein the oxidative product 
and the reductive product are used as part of a decontamina 
tion process. 
10. The method of claim 1, wherein one of the oxidative 
product and the reductive product is a gas and the other is an 
1O. 
11. The method of claim 1, wherein the amount of the 
electrochemical product is increased by exposing an area of 
the counter electrode to the electrolyte solution that was pre 
viously unexposed to the electrolyte solution. 
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